Antiviral Drugs for Viruses Other Than Human Immunodeficiency Virus
Most viral diseases, with the exception of those caused by human immunodeficiency virus, are self-limited illnesses that do not require specific antiviral therapy. The currently available antiviral drugs target 3 main groups of viruses: herpes, hepatitis, and influenza viruses. With the exception of...
Gespeichert in:
| Veröffentlicht in: | Mayo Clinic proceedings Jg. 86; H. 10; S. 1009 - 1026 |
|---|---|
| 1. Verfasser: | |
| Format: | Journal Article |
| Sprache: | Englisch |
| Veröffentlicht: |
Rochester, MN
Elsevier Inc
01.10.2011
Mayo Foundation Elsevier, Inc Elsevier Limited Mayo Foundation for Medical Education and Research |
| Schlagworte: | |
| ISSN: | 0025-6196, 1942-5546, 1942-5546 |
| Online-Zugang: | Volltext |
| Tags: |
Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
|
| Abstract | Most viral diseases, with the exception of those caused by human immunodeficiency virus, are self-limited illnesses that do not require specific antiviral therapy. The currently available antiviral drugs target 3 main groups of viruses: herpes, hepatitis, and influenza viruses. With the exception of the antisense molecule fomivirsen, all antiherpes drugs inhibit viral replication by serving as competitive substrates for viral DNA polymerase. Drugs for the treatment of influenza inhibit the ion channel M
2 protein or the enzyme neuraminidase. Combination therapy with Interferon-α and ribavirin remains the backbone treatment for chronic hepatitis C; the addition of serine protease inhibitors improves the treatment outcome of patients infected with hepatitis C virus genotype 1. Chronic hepatitis B can be treated with interferon or a combination of nucleos(t)ide analogues. Notably, almost all the nucleos(t) ide analogues for the treatment of chronic hepatitis B possess anti-human immunodeficiency virus properties, and they inhibit replication of hepatitis B virus by serving as competitive substrates for its DNA polymerase. Some antiviral drugs possess multiple potential clinical applications, such as ribavirin for the treatment of chronic hepatitis C and respiratory syncytial virus and cidofovir for the treatment of cytomegalovirus and other DNA viruses. Drug resistance is an emerging threat to the clinical utility of antiviral drugs. The major mechanisms for drug resistance are mutations in the viral DNA polymerase gene or in genes that encode for the viral kinases required for the activation of certain drugs such as acyclovir and ganciclovir. Widespread antiviral resistance has limited the clinical utility of M
2 inhibitors for the prevention and treatment of influenza infections. This article provides an overview of clinically available antiviral drugs for the primary care physician, with a special focus on pharmacology, clinical uses, and adverse effects. |
|---|---|
| AbstractList | Most viral diseases, with the exception of those caused by human immunodeficiency virus, are self-limited illnesses that do not require specific antiviral therapy. The currently available antiviral drugs target 3 main groups of viruses: herpes, hepatitis, and influenza viruses. With the exception of the antisense molecule fomivirsen, all antiherpes drugs inhibit viral replication by serving as competitive substrates for viral DNA polymerase. Drugs for the treatment of influenza inhibit the ion channel M(2) protein or the enzyme neuraminidase. Combination therapy with Interferon-α and ribavirin remains the backbone treatment for chronic hepatitis C; the addition of serine protease inhibitors improves the treatment outcome of patients infected with hepatitis C virus genotype 1. Chronic hepatitis B can be treated with interferon or a combination of nucleos(t)ide analogues. Notably, almost all the nucleos(t) ide analogues for the treatment of chronic hepatitis B possess anti-human immunodeficiency virus properties, and they inhibit replication of hepatitis B virus by serving as competitive substrates for its DNA polymerase. Some antiviral drugs possess multiple potential clinical applications, such as ribavirin for the treatment of chronic hepatitis C and respiratory syncytial virus and cidofovir for the treatment of cytomegalovirus and other DNA viruses. Drug resistance is an emerging threat to the clinical utility of antiviral drugs. The major mechanisms for drug resistance are mutations in the viral DNA polymerase gene or in genes that encode for the viral kinases required for the activation of certain drugs such as acyclovir and ganciclovir. Widespread antiviral resistance has limited the clinical utility of M(2) inhibitors for the prevention and treatment of influenza infections. This article provides an overview of clinically available antiviral drugs for the primary care physician, with a special focus on pharmacology, clinical uses, and adverse effects. Most viral diseases, with the exception of those caused by human immunodeficiency virus, are self-limited illnesses that do not require specific antiviral therapy. The currently available antiviral drugs target 3 main groups of viruses: herpes, hepatitis, and influenza viruses. With the exception of the antisense molecule fomivirsen, all antiherpes drugs inhibit viral replication by serving as competitive substrates for viral DNA polymerase. Drugs for the treatment of influenza inhibit the ion channel M 2 protein or the enzyme neuraminidase. Combination therapy with Interferon-α and ribavirin remains the backbone treatment for chronic hepatitis C; the addition of serine protease inhibitors improves the treatment outcome of patients infected with hepatitis C virus genotype 1. Chronic hepatitis B can be treated with interferon or a combination of nucleos(t)ide analogues. Notably, almost all the nucleos(t) ide analogues for the treatment of chronic hepatitis B possess anti-human immunodeficiency virus properties, and they inhibit replication of hepatitis B virus by serving as competitive substrates for its DNA polymerase. Some antiviral drugs possess multiple potential clinical applications, such as ribavirin for the treatment of chronic hepatitis C and respiratory syncytial virus and cidofovir for the treatment of cytomegalovirus and other DNA viruses. Drug resistance is an emerging threat to the clinical utility of antiviral drugs. The major mechanisms for drug resistance are mutations in the viral DNA polymerase gene or in genes that encode for the viral kinases required for the activation of certain drugs such as acyclovir and ganciclovir. Widespread antiviral resistance has limited the clinical utility of M 2 inhibitors for the prevention and treatment of influenza infections. This article provides an overview of clinically available antiviral drugs for the primary care physician, with a special focus on pharmacology, clinical uses, and adverse effects. Abstract Most viral diseases, with the exception of those caused by human immunodeficiency virus, are self-limited illnesses that do not require specific antiviral therapy. The currently available antiviral drugs target 3 main groups of viruses: herpes, hepatitis, and influenza viruses. With the exception of the antisense molecule fomivirsen, all antiherpes drugs inhibit viral replication by serving as competitive substrates for viral DNA polymerase. Drugs for the treatment of influenza inhibit the ion channel M2 protein or the enzyme neuraminidase. Combination therapy with Interferon-α and ribavirin remains the backbone treatment for chronic hepatitis C; the addition of serine protease inhibitors improves the treatment outcome of patients infected with hepatitis C virus genotype 1. Chronic hepatitis B can be treated with interferon or a combination of nucleos(t)ide analogues. Notably, almost all the nucleos(t) ide analogues for the treatment of chronic hepatitis B possess anti-human immunodeficiency virus properties, and they inhibit replication of hepatitis B virus by serving as competitive substrates for its DNA polymerase. Some antiviral drugs possess multiple potential clinical applications, such as ribavirin for the treatment of chronic hepatitis C and respiratory syncytial virus and cidofovir for the treatment of cytomegalovirus and other DNA viruses. Drug resistance is an emerging threat to the clinical utility of antiviral drugs. The major mechanisms for drug resistance are mutations in the viral DNA polymerase gene or in genes that encode for the viral kinases required for the activation of certain drugs such as acyclovir and ganciclovir. Widespread antiviral resistance has limited the clinical utility of M2 inhibitors for the prevention and treatment of influenza infections. This article provides an overview of clinically available antiviral drugs for the primary care physician, with a special focus on pharmacology, clinical uses, and adverse effects. Most viral diseases, with the exception of those caused by human immunodeficiency virus, are self-limited illnesses that do not require specific antiviral therapy. The currently available antiviral drugs target 3 main groups of viruses: herpes, hepatitis, and influenza viruses. With the exception of the antisense molecule fomivirsen, all antiherpes drugs inhibit viral replication by serving as competitive substrates for viral DNA polymerase. Drugs for the treatment of influenza inhibit the ion channel M2 protein or the enzyme neuraminidase. Combination therapy with Interferon-α and ribavirin remains the backbone treatment for chronic hepatitis C; the addition of serine protease inhibitors improves the treatment outcome of patients infected with hepatitis C virus genotype 1. Chronic hepatitis B can be treated with interferon or a combination of nucleos(t)ide analogues. Notably, almost all the nucleos(t) ide analogues for the treatment of chronic hepatitis B possess anti–human immunodeficiency virus properties, and they inhibit replication of hepatitis B virus by serving as competitive substrates for its DNA polymerase. Some antiviral drugs possess multiple potential clinical applications, such as ribavirin for the treatment of chronic hepatitis C and respiratory syncytial virus and cidofovir for the treatment of cytomegalovirus and other DNA viruses. Drug resistance is an emerging threat to the clinical utility of antiviral drugs. The major mechanisms for drug resistance are mutations in the viral DNA polymerase gene or in genes that encode for the viral kinases required for the activation of certain drugs such as acyclovir and ganciclovir. Widespread antiviral resistance has limited the clinical utility of M2 inhibitors for the prevention and treatment of influenza infections. This article provides an overview of clinically available antiviral drugs for the primary care physician, with a special focus on pharmacology, clinical uses, and adverse effects. Most viral diseases, with the exception of those caused by human immunodeficiency virus, are self-limited illnesses that do not require specific antiviral therapy. The currently available antiviral drugs target 3 main groups of viruses: herpes, hepatitis, and influenza viruses. With the exception of the antisense molecule fomivirsen, all antiherpes drugs inhibit viral replication by serving as competitive substrates for viral DNA polymerase. Drugs for the treatment of influenza inhibit the ion channel M(2) protein or the enzyme neuraminidase. Combination therapy with Interferon-α and ribavirin remains the backbone treatment for chronic hepatitis C; the addition of serine protease inhibitors improves the treatment outcome of patients infected with hepatitis C virus genotype 1. Chronic hepatitis B can be treated with interferon or a combination of nucleos(t)ide analogues. Notably, almost all the nucleos(t) ide analogues for the treatment of chronic hepatitis B possess anti-human immunodeficiency virus properties, and they inhibit replication of hepatitis B virus by serving as competitive substrates for its DNA polymerase. Some antiviral drugs possess multiple potential clinical applications, such as ribavirin for the treatment of chronic hepatitis C and respiratory syncytial virus and cidofovir for the treatment of cytomegalovirus and other DNA viruses. Drug resistance is an emerging threat to the clinical utility of antiviral drugs. The major mechanisms for drug resistance are mutations in the viral DNA polymerase gene or in genes that encode for the viral kinases required for the activation of certain drugs such as acyclovir and ganciclovir. Widespread antiviral resistance has limited the clinical utility of M(2) inhibitors for the prevention and treatment of influenza infections. This article provides an overview of clinically available antiviral drugs for the primary care physician, with a special focus on pharmacology, clinical uses, and adverse effects.Most viral diseases, with the exception of those caused by human immunodeficiency virus, are self-limited illnesses that do not require specific antiviral therapy. The currently available antiviral drugs target 3 main groups of viruses: herpes, hepatitis, and influenza viruses. With the exception of the antisense molecule fomivirsen, all antiherpes drugs inhibit viral replication by serving as competitive substrates for viral DNA polymerase. Drugs for the treatment of influenza inhibit the ion channel M(2) protein or the enzyme neuraminidase. Combination therapy with Interferon-α and ribavirin remains the backbone treatment for chronic hepatitis C; the addition of serine protease inhibitors improves the treatment outcome of patients infected with hepatitis C virus genotype 1. Chronic hepatitis B can be treated with interferon or a combination of nucleos(t)ide analogues. Notably, almost all the nucleos(t) ide analogues for the treatment of chronic hepatitis B possess anti-human immunodeficiency virus properties, and they inhibit replication of hepatitis B virus by serving as competitive substrates for its DNA polymerase. Some antiviral drugs possess multiple potential clinical applications, such as ribavirin for the treatment of chronic hepatitis C and respiratory syncytial virus and cidofovir for the treatment of cytomegalovirus and other DNA viruses. Drug resistance is an emerging threat to the clinical utility of antiviral drugs. The major mechanisms for drug resistance are mutations in the viral DNA polymerase gene or in genes that encode for the viral kinases required for the activation of certain drugs such as acyclovir and ganciclovir. Widespread antiviral resistance has limited the clinical utility of M(2) inhibitors for the prevention and treatment of influenza infections. This article provides an overview of clinically available antiviral drugs for the primary care physician, with a special focus on pharmacology, clinical uses, and adverse effects. |
| Audience | Academic |
| Author | Razonable, Raymund R. |
| AuthorAffiliation | From the Division of Infectious Diseases, Mayo Clinic, Rochester, MN |
| AuthorAffiliation_xml | – name: From the Division of Infectious Diseases, Mayo Clinic, Rochester, MN |
| Author_xml | – sequence: 1 givenname: Raymund R. surname: Razonable fullname: Razonable, Raymund R. email: razonable.raymund@mayo.edu organization: Division of Infectious Diseases, Mayo Clinic, Rochester, MN |
| BackLink | http://pascal-francis.inist.fr/vibad/index.php?action=getRecordDetail&idt=24595557$$DView record in Pascal Francis https://www.ncbi.nlm.nih.gov/pubmed/21964179$$D View this record in MEDLINE/PubMed |
| BookMark | eNp9kt1r2zAUxc3oWNNuj3sdZrDtydmVLMn2SyFkHy0U-rBur0KRrxN1tpRJdiD__eQly9pAhsEG-XeOdHTPRXJmncUkeU1gykDwj51eTykQMoUcqmfJhFSMZpwzcZZMACjPBKnEeXIRwgMAFFXFXiTnNK4xUlSTZD6zvdkYr9r0kx-WIW2cT38YPwQM6V2_Qp_er5RNr4cuvm-6brCuxsZog1Zvd-TL5Hmj2oCv9t_L5PuXz_fz6-z27uvNfHabaSFon-mFRq1QFyUTDBZQaCBAaMk4EbmgNQDhTaEL0HmZkxo4EF02QBdKIBGqyC-Tq53velh0WGu0fTy3XHvTKb-VThn59I81K7l0G5mTkkFOo8GHvYF3vwYMvexM0Ni2yqIbgiwrQRnEq4nk2yPywQ3exnQRYmVJBR_tpjtoqVqUxjYu7qrjU2NndBxTY-L6jBYxWA60ioL3jwQrVG2_Cq4deuNseAq-eZz0EPHv3CLwbg-ooFXbeGW1Cf84xivO-Xhl2Y7T3oXgsTkgBOTYHxn7I8f-yLE_kc-PeG16NZ4vRjPtSVWxU2Gc_sagl-FPP7A2HnUva2dOKq-OlLo11sRIP3GL4XDpRAYqQX4bGz0WmpA4AJaPBvy0wX82_g1oWf9r |
| CODEN | MACPAJ |
| CitedBy_id | crossref_primary_10_3390_v15030647 crossref_primary_10_1097_MOT_0b013e32835af316 crossref_primary_10_1002_rmv_1972 crossref_primary_10_3390_pharmaceutics12090875 crossref_primary_10_3390_ijms24010239 crossref_primary_10_3390_molecules25040942 crossref_primary_10_3390_pharmaceutics15010163 crossref_primary_10_1016_j_transproceed_2013_05_002 crossref_primary_10_1021_jacs_4c08371 crossref_primary_10_1007_BF03345024 crossref_primary_10_1016_j_lfs_2017_02_014 crossref_primary_10_1055_s_0039_1697930 crossref_primary_10_1134_S1070428024100014 crossref_primary_10_1038_srep04231 crossref_primary_10_1155_2017_5279065 crossref_primary_10_1111_liv_13506 crossref_primary_10_1007_s13205_023_03658_0 crossref_primary_10_1038_s41598_021_88153_3 crossref_primary_10_1053_j_gastro_2013_02_026 crossref_primary_10_3390_biom9100603 crossref_primary_10_1016_j_antiviral_2020_104713 crossref_primary_10_1002_etc_5127 crossref_primary_10_1016_j_bmc_2018_05_013 crossref_primary_10_1038_s41598_022_13635_x crossref_primary_10_1128_AAC_01072_12 crossref_primary_10_1016_j_antiviral_2014_10_011 crossref_primary_10_1158_0008_5472_CAN_11_2651 crossref_primary_10_4103_ijp_IJP_576_19 crossref_primary_10_1007_s00203_023_03478_z crossref_primary_10_1016_j_cell_2013_10_034 crossref_primary_10_1016_j_drudis_2023_103523 crossref_primary_10_2217_fvl_15_53 crossref_primary_10_3389_fimmu_2018_02147 crossref_primary_10_1002_ajoc_202100744 crossref_primary_10_1093_jac_dkaa272 crossref_primary_10_3390_molecules26102988 crossref_primary_10_3233_NPM_15814124 crossref_primary_10_1016_j_antiviral_2021_105018 crossref_primary_10_1089_cmb_2021_0108 crossref_primary_10_1186_s12348_023_00379_6 crossref_primary_10_1007_s40265_018_0943_1 crossref_primary_10_11144_Javeriana_SC293_gapr crossref_primary_10_1155_2021_5518825 crossref_primary_10_1007_s12560_017_9299_z crossref_primary_10_1007_s00044_023_03068_0 crossref_primary_10_1007_s00044_021_02700_1 crossref_primary_10_1016_j_cytogfr_2016_03_002 crossref_primary_10_1371_journal_pone_0285203 crossref_primary_10_1016_j_jsps_2020_08_015 crossref_primary_10_1016_j_antiviral_2016_07_014 crossref_primary_10_3389_fimmu_2017_00665 crossref_primary_10_1155_2012_586401 crossref_primary_10_1097_FTD_0000000000000925 crossref_primary_10_1016_j_ram_2018_01_003 crossref_primary_10_12968_ukve_2024_0037 crossref_primary_10_1016_j_ejphar_2020_173648 crossref_primary_10_1016_j_trim_2022_101539 crossref_primary_10_3389_fphar_2022_879733 crossref_primary_10_1080_10406638_2022_2127803 crossref_primary_10_1128_AAC_01301_19 crossref_primary_10_3390_molecules27217370 crossref_primary_10_3390_life12081287 crossref_primary_10_1016_j_chembiol_2022_03_007 crossref_primary_10_1016_j_tetlet_2013_05_062 crossref_primary_10_3851_IMP2129 crossref_primary_10_1016_j_jcyt_2016_05_005 crossref_primary_10_1016_j_bbrc_2020_06_123 crossref_primary_10_2174_0109298673294083240520044158 crossref_primary_10_1016_j_tvjl_2015_06_010 crossref_primary_10_1016_j_ophtha_2017_05_012 crossref_primary_10_1016_j_jpba_2017_06_071 crossref_primary_10_3390_v10090500 crossref_primary_10_3389_fphar_2023_1149909 crossref_primary_10_1007_s10593_019_02472_y crossref_primary_10_1016_j_bmc_2021_116366 crossref_primary_10_1021_acsomega_5c02121 crossref_primary_10_1186_s42466_019_0031_3 crossref_primary_10_1186_s13036_017_0089_9 crossref_primary_10_1080_08164622_2021_1877531 crossref_primary_10_3390_nano13192647 crossref_primary_10_1016_j_scitotenv_2019_134322 crossref_primary_10_1016_S1474_4422_12_70098_4 crossref_primary_10_3390_molecules25225245 crossref_primary_10_3389_fmicb_2016_00296 crossref_primary_10_36290_ped_2019_017 crossref_primary_10_1007_s13318_014_0200_2 crossref_primary_10_1016_j_jddst_2016_08_006 crossref_primary_10_1016_j_jsps_2019_01_004 crossref_primary_10_1128_CMR_00102_15 crossref_primary_10_1080_2162402X_2015_1115641 crossref_primary_10_1186_s43141_020_00081_3 crossref_primary_10_1016_j_tvjl_2014_11_011 crossref_primary_10_1016_j_coviro_2017_11_010 crossref_primary_10_1016_j_idc_2013_02_005 crossref_primary_10_1148_rg_2018170048 crossref_primary_10_1093_ofid_ofac494 crossref_primary_10_1016_j_semarthrit_2024_152396 crossref_primary_10_1016_j_teac_2019_e00071 crossref_primary_10_1002_viw2_16 crossref_primary_10_1038_s41598_017_15198_8 crossref_primary_10_1111_ane_12841 crossref_primary_10_1016_j_jpba_2017_07_003 crossref_primary_10_2217_fvl_2016_0129 crossref_primary_10_1016_j_semcancer_2020_03_011 crossref_primary_10_1080_14787210_2017_1266253 crossref_primary_10_1016_j_str_2013_06_013 crossref_primary_10_1089_mab_2020_0035 crossref_primary_10_1517_17425255_2012_680885 crossref_primary_10_1021_acs_jmedchem_5c00826 crossref_primary_10_1183_16000617_0038_2020 crossref_primary_10_3390_idr13020049 crossref_primary_10_1016_j_bmc_2013_01_021 crossref_primary_10_1073_pnas_1619114114 crossref_primary_10_1016_j_jhazmat_2023_131694 crossref_primary_10_3390_molecules25163760 crossref_primary_10_1177_10775587211004308 crossref_primary_10_1111_cbdd_12834 crossref_primary_10_1515_znc_2024_0176 crossref_primary_10_3390_app11125742 crossref_primary_10_1016_j_jcv_2016_10_003 crossref_primary_10_2146_ajhp120665 crossref_primary_10_1016_j_rvsc_2017_02_012 crossref_primary_10_1080_17512433_2018_1501557 crossref_primary_10_3389_fphar_2015_00304 crossref_primary_10_1002_chem_201704000 crossref_primary_10_1088_1755_1315_346_1_012041 crossref_primary_10_1002_jmv_23713 crossref_primary_10_1016_j_biotechadv_2017_12_016 crossref_primary_10_3390_v10100519 crossref_primary_10_1093_cid_ciaa1384 crossref_primary_10_3390_v5061447 crossref_primary_10_1111_ctr_13512 crossref_primary_10_1007_s00044_013_0819_6 crossref_primary_10_1016_j_scitotenv_2020_138277 crossref_primary_10_3389_fphar_2020_01196 crossref_primary_10_21307_PM_2019_58_3_291 crossref_primary_10_1099_jgv_0_001090 crossref_primary_10_1016_j_jinorgbio_2021_111660 crossref_primary_10_4236_vp_2021_72006 |
| Cites_doi | 10.1001/jama.1982.03320400044032 10.1517/14740338.6.2.155 10.1086/599829 10.1007/s15010-006-5103-y 10.1093/infdis/151.2.362 10.1128/AAC.00085-09 10.1056/NEJM198601023140104 10.1016/S0140-6736(07)61908-4 10.1182/blood-2005-09-3786 10.1056/NEJMoa040431 10.1038/ajg.2009.311 10.1002/hep.510240405 10.1086/431585 10.1056/NEJM200103293441303 10.1016/j.jhep.2005.03.003 10.1097/01.aids.0000216390.83351.87 10.1097/01.aids.0000163948.62176.e7 10.2165/00003088-200443090-00003 10.1111/j.1399-0012.2007.00761.x 10.2165/00003088-199936020-00004 10.1016/S0140-6736(95)91323-8 10.1093/infdis/164.6.1119 10.3390/v2122740 10.1080/13550280152537238 10.1086/378068 10.1177/0091270002239705 10.1086/523590 10.1016/j.jcv.2008.10.001 10.2165/00002018-199921040-00003 10.1002/hep.23190 10.1177/106002809402800908 10.1099/vir.2008.007260-0 10.7326/0003-4819-151-7-200910060-00143 10.1586/14787210.2.1.27 10.1097/00002030-200209060-00012 10.1056/NEJM199512213332501 10.1128/AAC.35.9.1741 10.1056/NEJM199905133401903 10.1093/clind/24.4.718 10.1056/NEJM199312023292321 10.1111/j.1600-6143.2009.02900.x 10.1056/NEJM200012073432302 10.3109/13550289809114533 10.2165/00003495-200363200-00007 10.1056/NEJMoa1012912 10.1002/ana.1062 10.1016/j.jcv.2004.02.009 10.1093/jac/dki018 10.1046/j.1365-2133.2002.04747.x 10.1097/TP.0b013e3181cee42f 10.1001/jama.297.13.1435 10.1111/j.1600-6143.2007.01910.x 10.1056/NEJMoa0806104 10.1056/NEJMoa1010494 10.1093/clinids/22.2.341 10.1056/NEJMoa042957 10.4065/76.11.1171 10.1056/NEJMoa1013086 10.1016/S0140-6736(01)06102-5 10.2174/092986708783955419 10.1093/infdis/168.2.444 10.1093/jac/32.suppl_A.121 10.2165/00003495-200060060-00007 10.1093/jac/dkl067 10.1056/NEJM198401053100107 10.1086/375058 10.1056/NEJMoa066422 10.1056/NEJMoa020681 10.2165/00003495-200969080-00005 10.1016/S0140-6736(09)61528-2 10.1016/S0140-6736(04)16934-1 10.1128/AAC.39.7.1599 10.2165/00002018-200124150-00003 10.1002/hep.21307 10.1016/j.jaad.2006.01.007 10.1111/j.1600-6143.2004.00382.x 10.1345/aph.1D362 10.1056/NEJMoa032653 10.1016/S0021-9258(17)43446-6 10.1056/NEJMoa011759 10.7326/0003-4819-98-6-914 10.1056/NEJM200012073432301 10.1177/106002809703100211 10.1111/j.1399-3062.2005.00099.x 10.1128/AAC.34.3.489 10.1345/aph.1G027 10.1001/archinte.166.1.49 10.1007/s00428-007-0418-3 10.2165/00003495-199652020-00006 10.1176/appi.ajp.157.6.867 10.1345/aph.17135 10.1086/523589 10.1001/archinte.1987.00370090055011 10.7326/0003-4819-147-11-200712040-00183 10.1056/NEJMoa0807650 10.7326/0003-4819-98-6-921 10.1128/JCM.42.1.242-249.2004 10.1093/infdis/168.3.557 10.7326/0003-4819-119-4-199308150-00011 10.1111/j.1742-1241.2006.01143.x 10.1016/S0140-6736(97)05535-9 10.1093/infdis/170.3.570 10.1177/0091270009333555 10.1001/jama.2009.294 10.1097/00006454-200111000-00016 10.1002/(SICI)1098-0997(1998)6:1<38::AID-IDOG8>3.0.CO;2-3 10.1111/j.1600-6143.2009.02901.x 10.2165/00003495-199141010-00009 10.1016/j.jhep.2004.11.021 10.1111/j.1600-6143.2006.01413.x 10.1053/j.gastro.2007.03.116 10.1056/NEJM199910213411702 10.1592/phco.27.4.494 10.1001/archinte.168.11.1137 10.2165/00003088-200544050-00003 10.1001/jama.1997.03540410052030 10.1345/aph.1P744 10.2165/00003088-199936010-00004 10.1089/apc.2007.0052 10.1016/S0140-6736(05)17701-0 10.1358/dot.2001.37.4.620590 10.1002/hep.22759 10.1056/NEJM199401133300202 10.1053/jlts.2002.34966 10.1016/S0140-6736(95)91829-9 10.2165/00003088-199631010-00001 10.1001/jama.292.23.2839 10.1056/NEJMoa020047 10.1016/j.clinthera.2006.02.012 10.1345/aph.17453 10.1016/S0002-9343(99)00041-8 10.1093/jac/dki405 10.1128/AAC.40.12.2721 10.1093/jac/dkm143 10.1016/S0140-6736(82)90658-4 10.1542/peds.99.2.261 10.7326/0003-4819-117-5-358 10.1056/NEJMoa021812 10.1159/000065841 10.1111/j.1365-2125.2006.02704.x 10.1128/CMR.16.1.114-128.2003 10.2165/00003495-199550050-00007 10.1056/NEJM199509073331002 10.1053/j.gastro.2007.02.037 10.1016/S0022-3476(05)81618-X 10.1056/NEJMoa043470 10.1345/aph.17312 10.1128/AAC.38.10.2454 10.1056/NEJMoa054512 10.1056/NEJMoa1009482 10.1055/s-2004-830372 10.2165/00003495-200161150-00013 10.1056/NEJM198610233151704 10.1056/NEJMoa040842 10.1093/infdis/150.1.1 10.1128/AAC.42.9.2240 10.1592/phco.26.12.1745 10.1053/j.gastro.2004.03.017 10.1016/S0733-8635(02)00116-X 10.1086/499048 10.1086/589748 10.1177/106002809302701208 10.1016/0140-6736(90)92253-E 10.1001/jama.1984.03340400031020 10.1111/j.1600-6143.2009.02897.x 10.1345/aph.10338 10.1016/j.jhep.2007.12.006 10.1136/bjo.83.10.1153 10.1093/jac/dkl551 10.1016/S0140-6736(83)92618-1 10.1016/S1386-6532(99)00065-7 10.1086/378304 10.3310/hta13110 10.1038/4371108a 10.1056/NEJMc0910893 10.1016/j.bcp.2004.07.039 10.1056/NEJMoa011232 10.1007/s00705-003-0124-7 10.1016/j.healun.2008.10.008 10.1177/135965350801300806 10.2165/00003088-199937020-00005 10.1086/314487 10.1056/NEJM199807093390201 10.1001/archinte.1996.00440140169018 10.1016/0140-6736(91)92132-L 10.1345/aph.1C388 10.1186/1752-1947-2-94 10.1086/425746 10.1111/j.1365-2893.2005.00599.x |
| ContentType | Journal Article |
| Copyright | 2011 Mayo Foundation for Medical Education and Research Mayo Foundation for Medical Education and Research 2015 INIST-CNRS COPYRIGHT 2011 Elsevier, Inc. Copyright Mayo Foundation for Medical Education and Research Oct 2011 2011 Mayo Foundation for Medical Education and Research 2011 |
| Copyright_xml | – notice: 2011 Mayo Foundation for Medical Education and Research – notice: Mayo Foundation for Medical Education and Research – notice: 2015 INIST-CNRS – notice: COPYRIGHT 2011 Elsevier, Inc. – notice: Copyright Mayo Foundation for Medical Education and Research Oct 2011 – notice: 2011 Mayo Foundation for Medical Education and Research 2011 |
| DBID | AAYXX CITATION IQODW CGR CUY CVF ECM EIF NPM 3V. 4U- 7RV 7T5 7X7 7XB 88E 88I 8AF 8C1 8FI 8FJ 8FK ABUWG AFKRA AZQEC BEC BENPR CCPQU DWQXO FYUFA GHDGH GNUQQ H94 HCIFZ K9- K9. KB0 M0R M0S M1P M2P NAPCQ PHGZM PHGZT PJZUB PKEHL PPXIY PQEST PQQKQ PQUKI PRINS Q9U S0X 7X8 5PM |
| DOI | 10.4065/mcp.2011.0309 |
| DatabaseName | CrossRef Pascal-Francis Medline MEDLINE MEDLINE (Ovid) MEDLINE MEDLINE PubMed ProQuest Central (Corporate) University Readers Nursing & Allied Health Database Immunology Abstracts ProQuest_Health & Medical Collection ProQuest Central (purchase pre-March 2016) Medical Database (Alumni Edition) Science Database (Alumni Edition) STEM Database Public Health Database Hospital Premium Collection Hospital Premium Collection (Alumni Edition) ProQuest Central (Alumni) (purchase pre-March 2016) ProQuest Central (Alumni) ProQuest Central UK/Ireland ProQuest Central Essentials eLibrary Curriculum ProQuest Central ProQuest One ProQuest Central Health Research Premium Collection Health Research Premium Collection (Alumni) ProQuest Central Student AIDS and Cancer Research Abstracts SciTech Premium Collection Consumer Health Database ProQuest Health & Medical Complete (Alumni) Nursing & Allied Health Database (Alumni Edition) Consumer Health Database (ProQuest) ProQuest Health & Medical Collection Medical Database Science Database Nursing & Allied Health Premium ProQuest Central Premium ProQuest One Academic (New) ProQuest Health & Medical Research Collection ProQuest One Academic Middle East (New) ProQuest One Health & Nursing ProQuest One Academic Eastern Edition (DO NOT USE) ProQuest One Academic (retired) ProQuest One Academic UKI Edition ProQuest Central China ProQuest Central Basic SIRS Editorial MEDLINE - Academic PubMed Central (Full Participant titles) |
| DatabaseTitle | CrossRef MEDLINE Medline Complete MEDLINE with Full Text PubMed MEDLINE (Ovid) University Readers ProQuest Central Student ProQuest One Academic Middle East (New) ProQuest Central Essentials SIRS Editorial elibrary ProQuest Health & Medical Complete (Alumni) ProQuest AP Science ProQuest Central (Alumni Edition) SciTech Premium Collection ProQuest One Community College ProQuest One Health & Nursing ProQuest Family Health (Alumni Edition) ProQuest Central China ProQuest Central ProQuest Health & Medical Research Collection Health Research Premium Collection Health and Medicine Complete (Alumni Edition) ProQuest Central Korea Health & Medical Research Collection AIDS and Cancer Research Abstracts ProQuest Central (New) ProQuest Medical Library (Alumni) ProQuest Public Health ProQuest Science Journals (Alumni Edition) ProQuest Central Basic ProQuest Science Journals ProQuest Family Health ProQuest One Academic Eastern Edition ProQuest Nursing & Allied Health Source ProQuest Hospital Collection Health Research Premium Collection (Alumni) ProQuest Hospital Collection (Alumni) Nursing & Allied Health Premium ProQuest Health & Medical Complete ProQuest Medical Library ProQuest One Academic UKI Edition Immunology Abstracts ProQuest Nursing & Allied Health Source (Alumni) ProQuest One Academic ProQuest One Academic (New) ProQuest Central (Alumni) MEDLINE - Academic |
| DatabaseTitleList | MEDLINE University Readers MEDLINE - Academic |
| Database_xml | – sequence: 1 dbid: NPM name: PubMed url: http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed sourceTypes: Index Database – sequence: 2 dbid: 7RV name: Nursing & Allied Health Database url: https://search.proquest.com/nahs sourceTypes: Aggregation Database |
| DeliveryMethod | fulltext_linktorsrc |
| Discipline | Medicine |
| EISSN | 1942-5546 |
| EndPage | 1026 |
| ExternalDocumentID | PMC3184032 2472485591 A270153029 21964179 24595557 10_4065_mcp_2011_0309 S0025619611652439 1_s2_0_S0025619611652439 |
| Genre | Journal Article Review |
| GeographicLocations | United States |
| GeographicLocations_xml | – name: United States |
| GroupedDBID | --- --K .1- .55 .FO .GJ 08P 0R~ 18M 1CY 1P~ 29M 2WC 354 36B 3O- 4.4 457 53G 5GY 5RE 7RV 7X7 88E 88I 8AF 8C1 8F7 8FI 8FJ 96U AAEDT AAEDW AAKAS AALRI AAQQT AAQXK AAWTL AAXUO AAYEP ABCQX ABJNI ABLJU ABMAC ABUWG ABWVN ACGFO ACGOD ACPRK ACRPL ACVFH ADBBV ADCNI ADFRT ADMUD ADNMO ADZCM AENEX AERZD AEVXI AFAZI AFFNX AFJKZ AFKRA AFRHN AFTJW AGNAY AGQPQ AHMBA AITUG AJUYK ALMA_UNASSIGNED_HOLDINGS AMRAJ APXCP ASPBG AVWKF AZFZN AZQEC BAAKF BAWUL BCR BCU BEC BENPR BES BKEYQ BKNYI BKOMP BLC BPHCQ BVXVI CCPQU DIK DU5 DWQXO E3Z EBS EFKBS EJD EX3 F8P F9R FAS FDB FEDTE FGOYB FJW FYUFA GNUQQ GX1 H13 HCIFZ HMCUK HVGLF HYE HZ~ IAO IEA IHR IHW INH INR IOF ITC J5H K9- L7B M0R M1P M2P M2Q M41 N4W N95 NAPCQ O9- OD. OHT OK1 OO~ OVD P2P PCD PEA PHGZM PHGZT PJZUB PPXIY PQQKQ PROAC PSQYO R2- ROL RPM RVF RWL RXW S0X SEL SJFOW TAE TEORI TJF TR2 U5U UKHRP UNMZH VVN W8F WH7 WOW X7M XH2 YFH YOC Z5R ZGI ZXP 3V. AAYOK AFCTW ALIPV FAC ICW PKN RIG XI7 AAIAV AHPSJ ZA5 AAYXX AFFHD CITATION AGCQF IQODW CGR CUY CVF ECM EIF NPM 4U- 7T5 7XB 8FK H94 K9. PKEHL PQEST PQUKI PRINS Q9U 7X8 PUEGO 5PM |
| ID | FETCH-LOGICAL-c662t-cbcecaec784640b07c0101284516362d0015f7c70c3831d0501c8f02ba6e16a73 |
| IEDL.DBID | 7RV |
| ISICitedReferencesCount | 161 |
| ISICitedReferencesURI | http://www.webofscience.com/api/gateway?GWVersion=2&SrcApp=Summon&SrcAuth=ProQuest&DestLinkType=CitingArticles&DestApp=WOS_CPL&KeyUT=000295664300012&url=https%3A%2F%2Fcvtisr.summon.serialssolutions.com%2F%23%21%2Fsearch%3Fho%3Df%26include.ft.matches%3Dt%26l%3Dnull%26q%3D |
| ISSN | 0025-6196 1942-5546 |
| IngestDate | Tue Nov 04 01:49:48 EST 2025 Sun Sep 28 11:52:50 EDT 2025 Tue Oct 07 05:35:39 EDT 2025 Tue Nov 04 17:43:40 EST 2025 Thu May 22 21:25:28 EDT 2025 Thu Apr 03 07:09:17 EDT 2025 Mon Jul 21 09:17:56 EDT 2025 Sat Nov 29 02:28:21 EST 2025 Tue Nov 18 21:26:10 EST 2025 Fri Feb 23 02:18:37 EST 2024 Sun Feb 23 10:19:58 EST 2025 Tue Oct 14 19:36:31 EDT 2025 |
| IsDoiOpenAccess | true |
| IsOpenAccess | true |
| IsPeerReviewed | true |
| IsScholarly | true |
| Issue | 10 |
| Keywords | FDA HBeAg ALT HSV mRNA CMV HSV-2 IV SVR SC HSV-1 VZV HIV RSV CSF HHV TK EBV HCV CHB HBV I FN CHC human herpesvirus thymidine kinase hepatitis B virus alanine aminotransferase hepatitis B e antigen herpes simplex virus subcutaneous intravenous cytomegalovirus messenger RNA hepatitis C virus Epstein-Barr virus US Food and Drug Administration sustained virologic response chronic hepatitis B chronic hepatitis C interferon HSV type 2 HSV type 1 cerebrospinal fluid human immunodeficiency virus varicella zoster virus respiratory syncytial virus Infection Virus Medicine Drug Immunopathology Viral disease Retroviridae Antiviral AIDS Human immunodeficiency virus Immune deficiency Lentivirus |
| Language | English |
| License | CC BY 4.0 |
| LinkModel | DirectLink |
| MergedId | FETCHMERGED-LOGICAL-c662t-cbcecaec784640b07c0101284516362d0015f7c70c3831d0501c8f02ba6e16a73 |
| Notes | ObjectType-Article-2 SourceType-Scholarly Journals-1 ObjectType-General Information-1 content type line 14 ObjectType-Feature-3 ObjectType-Article-1 ObjectType-Feature-2 ObjectType-Review-3 content type line 23 |
| OpenAccessLink | https://pubmed.ncbi.nlm.nih.gov/PMC3184032 |
| PMID | 21964179 |
| PQID | 894882652 |
| PQPubID | 48850 |
| PageCount | 18 |
| ParticipantIDs | pubmedcentral_primary_oai_pubmedcentral_nih_gov_3184032 proquest_miscellaneous_896240964 proquest_journals_894882652 gale_infotracacademiconefile_A270153029 gale_healthsolutions_A270153029 pubmed_primary_21964179 pascalfrancis_primary_24595557 crossref_primary_10_4065_mcp_2011_0309 crossref_citationtrail_10_4065_mcp_2011_0309 elsevier_sciencedirect_doi_10_4065_mcp_2011_0309 elsevier_clinicalkeyesjournals_1_s2_0_S0025619611652439 elsevier_clinicalkey_doi_10_4065_mcp_2011_0309 |
| PublicationCentury | 2000 |
| PublicationDate | 2011-10-01 |
| PublicationDateYYYYMMDD | 2011-10-01 |
| PublicationDate_xml | – month: 10 year: 2011 text: 2011-10-01 day: 01 |
| PublicationDecade | 2010 |
| PublicationPlace | Rochester, MN |
| PublicationPlace_xml | – name: Rochester, MN – name: England – name: Rochester |
| PublicationTitle | Mayo Clinic proceedings |
| PublicationTitleAlternate | Mayo Clin Proc |
| PublicationYear | 2011 |
| Publisher | Elsevier Inc Mayo Foundation Elsevier, Inc Elsevier Limited Mayo Foundation for Medical Education and Research |
| Publisher_xml | – name: Elsevier Inc – name: Mayo Foundation – name: Elsevier, Inc – name: Elsevier Limited – name: Mayo Foundation for Medical Education and Research |
| References | De Clercq (bib91) 2004; 30 de Jong, Tran, Truong (bib102) 2005; 353 Knowles, Phillips, Dresser, Matukas (bib154) 2003; 37 Gravenstein, Johnston, Loeschel, Webster (bib109) 2001; 24 Lor, Liu (bib64) 1994; 28 De Clercq (bib26) 2004; 68 Farci, Roskams, Chessa (bib120) 2004; 126 Zeuzem, Andreone, Pol (bib202) 2011; 364 Foote BC, Spooner LM, Belliveau PP. Boceprevir: a protease inhibitor for the treatment of chronic hepatitis C [Epub ahead of print August 9, 2011]. Midturi, Sierra-Hoffman, Hurley, Winn, Beissner, Carpenter (bib142) 2004; 39 Humar, Snydman (bib61) 2009; 9 Balfour, Fletcher, Erice (bib59) 1996; 40 Agesta, Zabala, Diaz-Perez (bib147) 2002; 205 Ward, Small, Smith, Suter, Dutkowski (bib98) 2005; 55 Kilgore, Ksiazek, Rollin (bib162) 1997; 24 Dienstag, Perrillo, Schiff, Bartholomew, Vicary, Rubin (bib175) 1995; 333 Wade, Meyers (bib19) 1983; 98 Renault, Hoofnagle, Park (bib140) 1987; 147 Poordad, McCone, Bacon (bib195) 2011; 364 Einsele, Reusser, Bornhauser (bib87) 2006; 107 Higgins, Eshaghi, Burton, Mazzulli, Drews (bib95) 2009; 44 Wade, Snoeck, Duff, Lamb, Jorga (bib148) 2006; 62 Helldén, Lycke, Vander, Svensson, Odar-Cederlof, Stahle (bib17) 2006; 57 Chan, Heathcote, Marcellin (bib183) 2007; 147 Kiso, Mitamura, Sakai-Tagawa (bib101) 2004; 364 Bacon, Levin, Leary, Sarisky, Sutton (bib23) 2003; 16 Razonable, Paya (bib67) 2002; 8 Jacobson, McHutchison, Dusheiko (bib201) 2011; 364 Zeuzem, Feinman, Rasenack (bib124) 2000; 343 Drew, Ives, Lalezari, Syntex Cooperative Oral Ganciclovir Study Group (bib69) 1995; 333 Matthews (bib172) 2006; 28 Kendle, Fan-Havard (bib31) 1998; 32 Cundy (bib30) 1999; 36 Pawlotsky, Chevaliez, McHutchison (bib197) 2007; 132 Ambati, Wynne, Angerame, Robinson (bib49) 1999; 83 Paya, Humar, Dominguez (bib84) 2004; 4 Khazeni, Bravata, Holty, Uyeki, Stave, Gould (bib100) 2009; 151 Garvey, Thomson, Taylor (bib41) 2006; 20 Wilhelmus (bib90) 2008 Ghany, Strader, Thomas, Seeff (bib130) 2009; 49 Dienstag, Schiff, Wright (bib176) 1999; 341 Gish (bib150) 2006; 57 Prochoda, Mostow, Greenberg (bib163) 1993; 329 Perazella (bib16) 1999; 106 Cha, Johnston, Natkunam, Brown (bib35) 2005; 7 Gupta, Warren, Wald (bib4) 2007; 370 Lamoth, Pascual, Erard, Venetz, Nseir, Meylan (bib36) 2008; 13 Hayden, Hay (bib96) 1992; 176 Bean, Aeppli (bib15) 1985; 151 Ernst, Franey (bib18) 1998; 32 Razonable, Paya (bib79) 2004; 2 doi:10.1345/aph.1P744. Marra, Rajicic, Barker (bib42) 2002; 16 (bib14) 2004; 4 Lowance, Neumayer, Legendre, International Valacyclovir Cytomegalovirus Prophylaxis Transplantation Study Group (bib78) 1999; 340 Snoeck, De Clercq (bib34) 2002; 3 Luby, Gnann, Alexander (bib6) 1984; 150 Malvy, Treilhaud, Bouee (bib24) 2005; 41 Kazory, Singapur!, Wadhwa, Ejaz (bib48) 2007; 60 Kramer, Gaar, Ray, Minnich, Copeland, Connor (bib149) 1990; 34 Manns, McHutchison, Gordon (bib129) 2001; 358 Pelaez, Lyon, Force (bib153) 2009; 28 Marcellin, Asselah, Boyer (bib115) 2005; 12 Sugaya, Tamura, Yamazaki (bib99) 2008; 47 Sims, Woodland (bib171) 2006; 26 Geschwind, Skolasky, Royal, McArthur (bib139) 2001; 7 Frank, Chiou, Cheng (bib66) 1984; 259 Faro (bib52) 1998; 6 Kotton, Kumar, Caliendo (bib60) 2010; 89 Mardani, Jahromi, Naieni, Zeinali (bib161) 2003; 36 Zhou, Ke, Sallas, Farrell, Mayers, Pentikis (bib179) 2009; 49 Sarisky, Bacon, Boon (bib72) 2003; 148 Dharan, Gubareva, Meyer (bib104) 2009; 301 Lea, Bryson (bib27) 1996; 52 Spruance, Rea, Thoming, Tucker, Saltzman, Boon, Topical Penciclovir Collaborative Study Group (bib74) 1997; 277 Eid, Arthurs, Deziel, Wilhelm, Razonable (bib71) 2008; 22 Corey, Fife, Benedetti (bib1) 1983; 98 Wong, Lok (bib187) 2006; 44 Reichman, Badger, Mertz (bib5) 1984; 251 Amos, Amess (bib21) 1983; 1 Kopp, Geusau, Rieger, Stingl (bib40) 2002; 147 Dieperink, Willenbring, Ho (bib141) 2000; 157 Superti, Ammendolia, Marchetti (bib25) 2008; 15 Kearney, Flaherty, Shah (bib184) 2004; 43 Nichols, Boeckh (bib65) 2000; 16 Gane, Saliba, Valdecasas, Oral Ganciclovir International Transplantation Study Group (bib70) 1997; 350 Honkoop, de Man, Heijtink, Schalm (bib178) 1995; 346 Kottke, Parker (bib47) 2006; 55 Bacon, Gordon, Lawitz (bib196) 2011; 364 Vitravene Study Group (bib56) 2002; 133 Razonable, Aksamit, Wright, Wilson (bib43) 2001; 76 Santantonio, Fasano, Sinisi (bib135) 2005; 42 Gallant, Deresinski (bib186) 2003; 37 Balfour, Kelly, Suarez (bib11) 1990; 116 Spector, Weingeist, Pollard, AIDS Clinical Trials Group; Cytomegalovirus Cooperative Study Group (bib68) 1993; 168 Rivkin (bib165) 2004; 38 Hayden, Sperber, Belshe, Clover, Hay, Pyke (bib97) 1991; 35 Fisher-Hoch, Khan, Rehman, Mirza, Khurshid, McCormick (bib160) 1995; 346 Levenson, Fallon (bib143) 1993; 88 Lim, Ng, Kung (bib170) 2006; 166 Dando, Plosker (bib164) 2003; 63 Huang, Skolasky, Dal Pan, Royal, McArthur (bib138) 1998; 4 McHutchison, Everson, Gordon (bib199) 2009; 360 Toro, Sanchez, Turiansky, Blauvelt (bib37) 2003; 21 Grim, Romanelli (bib185) 2003; 37 Hézode, Forestier, Dusheiko (bib200) 2009; 360 Nilsen, Aasen, Halsos (bib2) 1982; 2 Jacobson, Causey, Polsky (bib62) 1993; 168 Krumbholz, Schmidtke, Bergmann (bib94) 2009; 90 Alberti, Clumeck, Collins (bib122) 2005; 42 Delaney (bib169) 2007; 59 Kidd, Down, Nastouli (bib108) 2009; 374 Johnson, Moore, Yuen, Bye, Pakes (bib174) 1999; 36 De Clercq (bib9) 1993; 32 Valencia, Miles, Melvin (bib10) 2004; 35 Gupta (bib190) 2008; 22 McCormick, King, Webb (bib158) 1986; 314 Martin, Sierra-Madero, Walmsley (bib83) 2002; 346 Serota, Starr, Bryan, Koch, Plotkin, August (bib3) 1982; 247 Wong, Cheung, O'Rourke, Naylor, Detsky, Heathcote (bib112) 1993; 119 Ventre, Randolph (bib152) 2007 Gluud, Marchesini, Iorio (bib151) 2009; 104 Segarra-Newnham, Vodolo (bib44) 2001; 35 Wiltshire, Hirankarn, Farrell (bib81) 2005; 44 Gaur, Bagga, Barman (bib107) 2010; 362 Torriani, Rodriguez-Torres, Rockstroh (bib132) 2004; 351 Gitman, Hirschwerk, Baskin, Singhal (bib189) 2007; 6 Buck, Vittone, Zaglul (bib20) 1993; 27 Lalezari, Drew, Glutzer (bib38) 1994; 170 Leung, Sacks (bib137) 2000; 60 Chong, Kamarulzaman, Tan (bib157) 2001; 49 Marcellin, Lau, Bonino (bib117) 2004; 351 Marcellin, Chang, Lim (bib166) 2003; 348 Gill, Wood (bib51) 1996; 31 Zeuzem, Welsch, Herrmann (bib110) 2003; 23 Lanier, Trost, Tippin (bib28) 2010; 2 Saltzman, Jurewicz, Boon (bib54) 1994; 38 Cernik, Gallina, Brodell (bib7) 2008; 168 Freund, Gravenstein, Elliott, Miller (bib106) 1999; 21 Len, Gavalda, Aguado (bib88) 2008; 46 Chung, Andersen, Volberding (bib133) 2004; 351 Chacko, Weinberg (bib53) 2007; 80 Jaeckel, Cornberg, Wedemeyer (bib134) 2001; 345 Soriano, Puoti, Bonacini (bib121) 2005; 19 Haria, Benfield (bib113) 1995; 50 Lai, Gane, Liaw (bib182) 2007; 357 Reijnders, Janssen (bib188) 2008; 48 Sarrazin, Kieffer, Bartels (bib198) 2007; 132 Danve-Szatanek, Aymard, Thouvenot (bib22) 2004; 42 Jabs, Enger, Forman, Dunn, The Cytomegalovirus Retinitis and Viral Resistance Study Group (bib33) 1998; 42 Musselman, Lawson, Gumnick (bib144) 2001; 344 Asberg, Humar, Rollag (bib89) 2007; 7 Zimmermann, Pizzoferrato, Bedford, Morris, Hoffman, Braden (bib193) 2006; 42 Hatakeyama, Sugaya, Ito (bib105) 2007; 297 Spruance, Tyring, DeGregorio, Miller, Beutner, Valaciclovir HSV Study Group (bib76) 1996; 156 Heathcote, Shiffman, Cooksley (bib126) 2000; 343 Kim, Park, Louie (bib180) 2006; 40 Wood, Kay, Dworkin, Soong, Whitley (bib13) 1996; 22 Caldes, Colom, Armendariz (bib82) 2009; 53 Lok, McMahon (bib114) 2009; 50 Jones, Nelson (bib181) 2006; 60 Fried, Shiffman, Reddy (bib128) 2002; 347 Bryant, Sasadeusz, Carapetis, Waters, Curtis (bib39) 2001; 20 Highleyman (bib57) 1998; 29 Pergam, Limaye (bib77) 2009; 9 Scott, Keating (bib173) 2009; 69 Kapitsinou, Ansari (bib192) 2008; 2 Poynard, Leroy, Cohard (bib123) 1996; 24 Tseng, Mortimer, Salit (bib50) 1999; 33 Cherrington, Fuller, Lamy (bib32) 1998; 178 Grillone, Lanz (bib55) 2001; 37 Muller, Dresser, Raboud (bib155) 2007; 27 Hadziyannis, Tassopoulos, Heathcote (bib167) 2003; 348 Wallace, Bowler, Murray, Brodine, Oldfield (bib12) 1992; 117 Brown, Banken, Saywell, Arum (bib80) 1999; 37 Snydman (bib86) 2008; 46 Bacon, Boyd (bib73) 1995; 39 McJunkin, Khan, de los Reyes (bib156) 1997; 99 Cesaro, Hirsch, Faraci (bib46) 2009; 49 Tappenden, Jackson, Cooper (bib92) 2009; 13 Zuckerman, Wald (bib8) 2009; 9 Beaufils, Deray, Katlama (bib63) 1990; 336 Farci, Mandas, Coiana (bib119) 1994; 330 Durand, Kaplanski, Portal, Scheiner, Berland, Soubeyrand (bib145) 1991; 338 Le, Kiso, Someya (bib103) 2005; 437 Janssen, van Zonneveld, Senturk (bib118) 2005; 365 Averbuch, Austin, Sherwin, Antonovych, Bunn, Longo (bib146) 1984; 310 Lai, Chien, Leung, Asia Hepatitis Lamivudine Study Group (bib177) 1998; 339 Viallard, Lazaro, Ellie (bib45) 2007; 35 Acosta, Fletcher (bib75) 1997; 31 Wolf, Rodriguez, Mucci, Ingrosso, Duncan, Nickens (bib29) 2003; 43 Schmid, Opravil, Moddel (bib191) 2007; 450 Khoury, Storch, Bohl (bib85) 2006; 6 Betts (bib93) 1989; 4 Perry, Jarvis (bib125) 2001; 61 Pedder (bib111) 2003; 23 Huggins, Hsiang, Cosgriff (bib159) 1991; 164 Hadziyannis, Tassopoulos, Heathcote (bib168) 2005; 352 Carrat, Bani-Sadr, Pol (bib131) 2004; 292 Eron, Judson, Tucker (bib136) 1986; 315 Chrisp, Clissold (bib58) 1991; 41 Brok, Gluud, Gluud (bib127) 2010 Lau, Piratvisuth, Luo (bib116) 2005; 352 Gupta (10.4065/mcp.2011.0309_bib190) 2008; 22 Gaur (10.4065/mcp.2011.0309_bib107) 2010; 362 Brown (10.4065/mcp.2011.0309_bib80) 1999; 37 Razonable (10.4065/mcp.2011.0309_bib43) 2001; 76 Lor (10.4065/mcp.2011.0309_bib64) 1994; 28 Reijnders (10.4065/mcp.2011.0309_bib188) 2008; 48 Einsele (10.4065/mcp.2011.0309_bib87) 2006; 107 Lai (10.4065/mcp.2011.0309_bib177) 1998; 339 Kapitsinou (10.4065/mcp.2011.0309_bib192) 2008; 2 Acosta (10.4065/mcp.2011.0309_bib75) 1997; 31 Cernik (10.4065/mcp.2011.0309_bib7) 2008; 168 Garvey (10.4065/mcp.2011.0309_bib41) 2006; 20 Betts (10.4065/mcp.2011.0309_bib93) 1989; 4 Chung (10.4065/mcp.2011.0309_bib133) 2004; 351 Danve-Szatanek (10.4065/mcp.2011.0309_bib22) 2004; 42 Marcellin (10.4065/mcp.2011.0309_bib166) 2003; 348 Kim (10.4065/mcp.2011.0309_bib180) 2006; 40 Wong (10.4065/mcp.2011.0309_bib112) 1993; 119 Brok (10.4065/mcp.2011.0309_bib127) 2010 Farci (10.4065/mcp.2011.0309_bib120) 2004; 126 Superti (10.4065/mcp.2011.0309_bib25) 2008; 15 Dando (10.4065/mcp.2011.0309_bib164) 2003; 63 Johnson (10.4065/mcp.2011.0309_bib174) 1999; 36 Valencia (10.4065/mcp.2011.0309_bib10) 2004; 35 Levenson (10.4065/mcp.2011.0309_bib143) 1993; 88 Prochoda (10.4065/mcp.2011.0309_bib163) 1993; 329 Gallant (10.4065/mcp.2011.0309_bib186) 2003; 37 Paya (10.4065/mcp.2011.0309_bib84) 2004; 4 Asberg (10.4065/mcp.2011.0309_bib89) 2007; 7 Luby (10.4065/mcp.2011.0309_bib6) 1984; 150 Delaney (10.4065/mcp.2011.0309_bib169) 2007; 59 Jacobson (10.4065/mcp.2011.0309_bib201) 2011; 364 Knowles (10.4065/mcp.2011.0309_bib154) 2003; 37 10.4065/mcp.2011.0309_bib194 Kottke (10.4065/mcp.2011.0309_bib47) 2006; 55 Schmid (10.4065/mcp.2011.0309_bib191) 2007; 450 Jacobson (10.4065/mcp.2011.0309_bib62) 1993; 168 Muller (10.4065/mcp.2011.0309_bib155) 2007; 27 Rivkin (10.4065/mcp.2011.0309_bib165) 2004; 38 Wallace (10.4065/mcp.2011.0309_bib12) 1992; 117 Farci (10.4065/mcp.2011.0309_bib119) 1994; 330 Chan (10.4065/mcp.2011.0309_bib183) 2007; 147 Kilgore (10.4065/mcp.2011.0309_bib162) 1997; 24 Gitman (10.4065/mcp.2011.0309_bib189) 2007; 6 Lamoth (10.4065/mcp.2011.0309_bib36) 2008; 13 Gane (10.4065/mcp.2011.0309_bib70) 1997; 350 Eron (10.4065/mcp.2011.0309_bib136) 1986; 315 Pelaez (10.4065/mcp.2011.0309_bib153) 2009; 28 Ghany (10.4065/mcp.2011.0309_bib130) 2009; 49 Manns (10.4065/mcp.2011.0309_bib129) 2001; 358 de Jong (10.4065/mcp.2011.0309_bib102) 2005; 353 Sugaya (10.4065/mcp.2011.0309_bib99) 2008; 47 Dharan (10.4065/mcp.2011.0309_bib104) 2009; 301 Eid (10.4065/mcp.2011.0309_bib71) 2008; 22 Lalezari (10.4065/mcp.2011.0309_bib38) 1994; 170 Corey (10.4065/mcp.2011.0309_bib1) 1983; 98 Wilhelmus (10.4065/mcp.2011.0309_bib90) 2008 Sarrazin (10.4065/mcp.2011.0309_bib198) 2007; 132 Nichols (10.4065/mcp.2011.0309_bib65) 2000; 16 Dienstag (10.4065/mcp.2011.0309_bib175) 1995; 333 Tseng (10.4065/mcp.2011.0309_bib50) 1999; 33 Alberti (10.4065/mcp.2011.0309_bib122) 2005; 42 Wolf (10.4065/mcp.2011.0309_bib29) 2003; 43 Cherrington (10.4065/mcp.2011.0309_bib32) 1998; 178 Malvy (10.4065/mcp.2011.0309_bib24) 2005; 41 Sims (10.4065/mcp.2011.0309_bib171) 2006; 26 Beaufils (10.4065/mcp.2011.0309_bib63) 1990; 336 Spruance (10.4065/mcp.2011.0309_bib74) 1997; 277 Len (10.4065/mcp.2011.0309_bib88) 2008; 46 De Clercq (10.4065/mcp.2011.0309_bib26) 2004; 68 Cha (10.4065/mcp.2011.0309_bib35) 2005; 7 Razonable (10.4065/mcp.2011.0309_bib67) 2002; 8 Jaeckel (10.4065/mcp.2011.0309_bib134) 2001; 345 Wood (10.4065/mcp.2011.0309_bib13) 1996; 22 Ernst (10.4065/mcp.2011.0309_bib18) 1998; 32 Drew (10.4065/mcp.2011.0309_bib69) 1995; 333 Hayden (10.4065/mcp.2011.0309_bib97) 1991; 35 Zhou (10.4065/mcp.2011.0309_bib179) 2009; 49 Serota (10.4065/mcp.2011.0309_bib3) 1982; 247 Perry (10.4065/mcp.2011.0309_bib125) 2001; 61 Hézode (10.4065/mcp.2011.0309_bib200) 2009; 360 Khazeni (10.4065/mcp.2011.0309_bib100) 2009; 151 Scott (10.4065/mcp.2011.0309_bib173) 2009; 69 Bacon (10.4065/mcp.2011.0309_bib196) 2011; 364 Dieperink (10.4065/mcp.2011.0309_bib141) 2000; 157 McJunkin (10.4065/mcp.2011.0309_bib156) 1997; 99 Kiso (10.4065/mcp.2011.0309_bib101) 2004; 364 Torriani (10.4065/mcp.2011.0309_bib132) 2004; 351 Huggins (10.4065/mcp.2011.0309_bib159) 1991; 164 Gish (10.4065/mcp.2011.0309_bib150) 2006; 57 (10.4065/mcp.2011.0309_bib14) 2004; 4 Amos (10.4065/mcp.2011.0309_bib21) 1983; 1 De Clercq (10.4065/mcp.2011.0309_bib9) 1993; 32 Bean (10.4065/mcp.2011.0309_bib15) 1985; 151 Midturi (10.4065/mcp.2011.0309_bib142) 2004; 39 Tappenden (10.4065/mcp.2011.0309_bib92) 2009; 13 Higgins (10.4065/mcp.2011.0309_bib95) 2009; 44 Bacon (10.4065/mcp.2011.0309_bib23) 2003; 16 Hatakeyama (10.4065/mcp.2011.0309_bib105) 2007; 297 Huang (10.4065/mcp.2011.0309_bib138) 1998; 4 Soriano (10.4065/mcp.2011.0309_bib121) 2005; 19 Lowance (10.4065/mcp.2011.0309_bib78) 1999; 340 Wade (10.4065/mcp.2011.0309_bib19) 1983; 98 Caldes (10.4065/mcp.2011.0309_bib82) 2009; 53 Matthews (10.4065/mcp.2011.0309_bib172) 2006; 28 Poordad (10.4065/mcp.2011.0309_bib195) 2011; 364 Sarisky (10.4065/mcp.2011.0309_bib72) 2003; 148 Lau (10.4065/mcp.2011.0309_bib116) 2005; 352 Jabs (10.4065/mcp.2011.0309_bib33) 1998; 42 Averbuch (10.4065/mcp.2011.0309_bib146) 1984; 310 Faro (10.4065/mcp.2011.0309_bib52) 1998; 6 Bacon (10.4065/mcp.2011.0309_bib73) 1995; 39 Wade (10.4065/mcp.2011.0309_bib148) 2006; 62 Buck (10.4065/mcp.2011.0309_bib20) 1993; 27 Musselman (10.4065/mcp.2011.0309_bib144) 2001; 344 Gupta (10.4065/mcp.2011.0309_bib4) 2007; 370 Bryant (10.4065/mcp.2011.0309_bib39) 2001; 20 Fisher-Hoch (10.4065/mcp.2011.0309_bib160) 1995; 346 Reichman (10.4065/mcp.2011.0309_bib5) 1984; 251 Marcellin (10.4065/mcp.2011.0309_bib115) 2005; 12 Ward (10.4065/mcp.2011.0309_bib98) 2005; 55 Honkoop (10.4065/mcp.2011.0309_bib178) 1995; 346 Pergam (10.4065/mcp.2011.0309_bib77) 2009; 9 Spruance (10.4065/mcp.2011.0309_bib76) 1996; 156 Zimmermann (10.4065/mcp.2011.0309_bib193) 2006; 42 Geschwind (10.4065/mcp.2011.0309_bib139) 2001; 7 Kopp (10.4065/mcp.2011.0309_bib40) 2002; 147 Marcellin (10.4065/mcp.2011.0309_bib117) 2004; 351 Segarra-Newnham (10.4065/mcp.2011.0309_bib44) 2001; 35 Balfour (10.4065/mcp.2011.0309_bib59) 1996; 40 Hadziyannis (10.4065/mcp.2011.0309_bib168) 2005; 352 Kazory (10.4065/mcp.2011.0309_bib48) 2007; 60 Snoeck (10.4065/mcp.2011.0309_bib34) 2002; 3 Kidd (10.4065/mcp.2011.0309_bib108) 2009; 374 Wiltshire (10.4065/mcp.2011.0309_bib81) 2005; 44 Hadziyannis (10.4065/mcp.2011.0309_bib167) 2003; 348 Cundy (10.4065/mcp.2011.0309_bib30) 1999; 36 Highleyman (10.4065/mcp.2011.0309_bib57) 1998; 29 Carrat (10.4065/mcp.2011.0309_bib131) 2004; 292 Kendle (10.4065/mcp.2011.0309_bib31) 1998; 32 Lai (10.4065/mcp.2011.0309_bib182) 2007; 357 Santantonio (10.4065/mcp.2011.0309_bib135) 2005; 42 Grim (10.4065/mcp.2011.0309_bib185) 2003; 37 Zeuzem (10.4065/mcp.2011.0309_bib110) 2003; 23 Freund (10.4065/mcp.2011.0309_bib106) 1999; 21 Chacko (10.4065/mcp.2011.0309_bib53) 2007; 80 Poynard (10.4065/mcp.2011.0309_bib123) 1996; 24 Wong (10.4065/mcp.2011.0309_bib187) 2006; 44 Grillone (10.4065/mcp.2011.0309_bib55) 2001; 37 Leung (10.4065/mcp.2011.0309_bib137) 2000; 60 Chong (10.4065/mcp.2011.0309_bib157) 2001; 49 Lok (10.4065/mcp.2011.0309_bib114) 2009; 50 Lea (10.4065/mcp.2011.0309_bib27) 1996; 52 De Clercq (10.4065/mcp.2011.0309_bib91) 2004; 30 Khoury (10.4065/mcp.2011.0309_bib85) 2006; 6 Gill (10.4065/mcp.2011.0309_bib51) 1996; 31 Le (10.4065/mcp.2011.0309_bib103) 2005; 437 Spector (10.4065/mcp.2011.0309_bib68) 1993; 168 Jones (10.4065/mcp.2011.0309_bib181) 2006; 60 Martin (10.4065/mcp.2011.0309_bib83) 2002; 346 Krumbholz (10.4065/mcp.2011.0309_bib94) 2009; 90 Nilsen (10.4065/mcp.2011.0309_bib2) 1982; 2 Viallard (10.4065/mcp.2011.0309_bib45) 2007; 35 Lim (10.4065/mcp.2011.0309_bib170) 2006; 166 Balfour (10.4065/mcp.2011.0309_bib11) 1990; 116 McCormick (10.4065/mcp.2011.0309_bib158) 1986; 314 Kearney (10.4065/mcp.2011.0309_bib184) 2004; 43 Frank (10.4065/mcp.2011.0309_bib66) 1984; 259 Haria (10.4065/mcp.2011.0309_bib113) 1995; 50 Toro (10.4065/mcp.2011.0309_bib37) 2003; 21 Vitravene Study Group (10.4065/mcp.2011.0309_bib56) 2002; 133 Zuckerman (10.4065/mcp.2011.0309_bib8) 2009; 9 Pedder (10.4065/mcp.2011.0309_bib111) 2003; 23 Helldén (10.4065/mcp.2011.0309_bib17) 2006; 57 Lanier (10.4065/mcp.2011.0309_bib28) 2010; 2 Saltzman (10.4065/mcp.2011.0309_bib54) 1994; 38 Ambati (10.4065/mcp.2011.0309_bib49) 1999; 83 Zeuzem (10.4065/mcp.2011.0309_bib124) 2000; 343 Janssen (10.4065/mcp.2011.0309_bib118) 2005; 365 Fried (10.4065/mcp.2011.0309_bib128) 2002; 347 Renault (10.4065/mcp.2011.0309_bib140) 1987; 147 Mardani (10.4065/mcp.2011.0309_bib161) 2003; 36 Dienstag (10.4065/mcp.2011.0309_bib176) 1999; 341 Agesta (10.4065/mcp.2011.0309_bib147) 2002; 205 Zeuzem (10.4065/mcp.2011.0309_bib202) 2011; 364 Hayden (10.4065/mcp.2011.0309_bib96) 1992; 176 Kotton (10.4065/mcp.2011.0309_bib60) 2010; 89 Marra (10.4065/mcp.2011.0309_bib42) 2002; 16 Snydman (10.4065/mcp.2011.0309_bib86) 2008; 46 McHutchison (10.4065/mcp.2011.0309_bib199) 2009; 360 Humar (10.4065/mcp.2011.0309_bib61) 2009; 9 Kramer (10.4065/mcp.2011.0309_bib149) 1990; 34 Cesaro (10.4065/mcp.2011.0309_bib46) 2009; 49 Pawlotsky (10.4065/mcp.2011.0309_bib197) 2007; 132 Chrisp (10.4065/mcp.2011.0309_bib58) 1991; 41 Gravenstein (10.4065/mcp.2011.0309_bib109) 2001; 24 Gluud (10.4065/mcp.2011.0309_bib151) 2009; 104 Perazella (10.4065/mcp.2011.0309_bib16) 1999; 106 Durand (10.4065/mcp.2011.0309_bib145) 1991; 338 Heathcote (10.4065/mcp.2011.0309_bib126) 2000; 343 Razonable (10.4065/mcp.2011.0309_bib79) 2004; 2 Ventre (10.4065/mcp.2011.0309_bib152) 2007 |
| References_xml | – volume: 360 start-page: 1839 year: 2009 end-page: 1850 ident: bib200 article-title: Telaprevir and peginterferon with or without ribavirin for chronic HCV infection publication-title: N Engl J Med – volume: 69 start-page: 1003 year: 2009 end-page: 1033 ident: bib173 article-title: Entecavir: a review of its use in chronic hepatitis B publication-title: Drugs – volume: 42 start-page: 242 year: 2004 end-page: 249 ident: bib22 article-title: Surveillance network for herpes simplex virus resistance to antiviral drugs: 3-year follow-up publication-title: J Clin Microbiol – volume: 104 start-page: 2335 year: 2009 end-page: 2341 ident: bib151 article-title: Peginterferon plus ribavirin for chronic hepatitis C in patients with human immunodeficiency virus publication-title: Am J Gastroenterol – volume: 4 start-page: 611 year: 2004 end-page: 620 ident: bib84 article-title: Efficacy and safety of valganciclovir vs. oral ganciclovir for prevention of cytomegalovirus disease in solid organ transplant recipients publication-title: Am J Transplant – volume: 178 start-page: 1821 year: 1998 end-page: 1825 ident: bib32 article-title: In vitro antiviral susceptibilities of isolates from cytomegalovirus retinitis patients receiving first- or second-line cidofovir therapy: relationship to clinical outcome publication-title: J Infect Dis – volume: 28 start-page: 1035 year: 1994 end-page: 1037 ident: bib64 article-title: Neurologic sequelae associated with foscarnet therapy publication-title: Ann Pharmacother – volume: 151 start-page: 362 year: 1985 end-page: 365 ident: bib15 article-title: Adverse effects of high-dose intravenous acyclovir in ambulatory patients with acute herpes zoster publication-title: J Infect Dis – volume: 55 start-page: 533 year: 2006 end-page: 536 ident: bib47 article-title: Intravenous cidofovir-induced resolution of disfiguring cutaneous human papillomavirus infection publication-title: J Am Acad Dermatol – start-page: CD002898 year: 2008 ident: bib90 article-title: Therapeutic interventions for herpes simplex virus epithelial keratitis publication-title: Cochrane Database Syst Rev – volume: 168 start-page: 1137 year: 2008 end-page: 1144 ident: bib7 article-title: The treatment of herpes simplex infections: an evidence-based review publication-title: Arch Intern Med – volume: 46 start-page: 20 year: 2008 end-page: 27 ident: bib88 article-title: Valganciclovir as treatment for cytomegalovirus disease in solid organ transplant recipients publication-title: Clin Infect Dis – volume: 352 start-page: 2682 year: 2005 end-page: 2695 ident: bib116 article-title: Peginterferon alfa-2a, lamivudine, and the combination for HBeAg-positive chronic hepatitis B publication-title: N Engl J Med – volume: 34 start-page: 489 year: 1990 end-page: 490 ident: bib149 article-title: Hemodialysis clearance of intravenously administered ribavirin publication-title: Antimicrob Agents Chemother – volume: 32 start-page: 121 year: 1993 end-page: 132 ident: bib9 article-title: Antivirals for the treatment of herpesvirus infections publication-title: J Antimicrob Chemother – volume: 31 start-page: 1 year: 1996 end-page: 8 ident: bib51 article-title: The clinical pharmacokinetics of famciclovir publication-title: Clin Pharmacokinet – volume: 35 start-page: 1741 year: 1991 end-page: 1747 ident: bib97 article-title: Recovery of drug-resistant influenza A virus during therapeutic use of rimantadine publication-title: Antimicrob Agents Chemother – volume: 28 start-page: 184 year: 2006 end-page: 203 ident: bib172 article-title: Entecavir for the treatment of chronic hepatitis B virus infection publication-title: Clin Ther – volume: 60 start-page: 1329 year: 2000 end-page: 1352 ident: bib137 article-title: Current recommendations for the treatment of genital herpes publication-title: Drugs – volume: 41 start-page: 104 year: 1991 end-page: 129 ident: bib58 article-title: Foscarnet: a review of its antiviral activity, pharmacokinetic properties and therapeutic use in immunocompromised patients with cytomegalovirus retinitis publication-title: Drugs – volume: 247 start-page: 2132 year: 1982 end-page: 2135 ident: bib3 article-title: Acyclovir treatment of herpes zoster infections: use in children undergoing bone marrow transplantation publication-title: JAMA – volume: 450 start-page: 665 year: 2007 end-page: 670 ident: bib191 article-title: Acute interstitial nephritis of HIV-positive patients under atazanavir and tenofovir therapy in a retrospective analysis of kidney biopsies publication-title: Virchows Arch – volume: 4 start-page: 324 year: 1998 end-page: 332 ident: bib138 article-title: Survival prolongation in HIV-associated progressive multifocal leukoencephalopathy treated with alpha-interferon: an observational study publication-title: J Neurovirol – volume: 22 start-page: 341 year: 1996 end-page: 347 ident: bib13 article-title: Oral acyclovir therapy accelerates pain resolution in patients with herpes zoster: a meta-analysis of placebo-controlled trials publication-title: Clin Infect Dis – volume: 98 start-page: 921 year: 1983 end-page: 925 ident: bib19 article-title: Neurologic symptoms associated with parenteral acyclovir treatment after marrow transplantation publication-title: Ann Intern Med – volume: 351 start-page: 451 year: 2004 end-page: 459 ident: bib133 article-title: Peginterferon Alfa-2a plus ribavirin versus interferon alfa-2a plus ribavirin for chronic hepatitis C in HIV-coinfected persons publication-title: N Engl J Med – volume: 6 start-page: 38 year: 1998 end-page: 43 ident: bib52 article-title: A review of famciclovir in the management of genital herpes publication-title: Infect Dis Obstet Gynecol – volume: 362 start-page: 88 year: 2010 end-page: 89 ident: bib107 article-title: Intravenous zanamivir for oseltamivir-resistant 2009 H1N1 influenza [letter] publication-title: N Engl J Med – volume: 6 start-page: 2134 year: 2006 end-page: 2143 ident: bib85 article-title: Prophylactic versus preemptive oral valganciclovir for the management of cytomegalovirus infection in adult renal transplant recipients publication-title: Am J Transplant – volume: 39 start-page: 1599 year: 1995 end-page: 1602 ident: bib73 article-title: Activity of penciclovir against Epstein-Barr virus publication-title: Antimicrob Agents Chemother – volume: 357 start-page: 2576 year: 2007 end-page: 2588 ident: bib182 article-title: Telbivudine versus lamivudine in patients with chronic hepatitis B publication-title: N Engl J Med – volume: 364 start-page: 759 year: 2004 end-page: 765 ident: bib101 article-title: Resistant influenza A viruses in children treated with oseltamivir: descriptive study publication-title: Lancet – volume: 2 start-page: 27 year: 2004 end-page: 41 ident: bib79 article-title: Valganciclovir for the prevention and treatment of cytomegalovirus disease in immunocompromised hosts publication-title: Expert Rev Anti Infect Ther – volume: 88 start-page: 760 year: 1993 end-page: 761 ident: bib143 article-title: Fluoxetine treatment of depression caused by interferon-alpha publication-title: Am J Gastroenterol – volume: 90 start-page: 900 year: 2009 end-page: 908 ident: bib94 article-title: High prevalence of amantadine resistance among circulating European porcine influenza A viruses publication-title: J Gen Virol – volume: 22 start-page: 162 year: 2008 end-page: 170 ident: bib71 article-title: Emergence of drug-resistant cytomegalovirus in the era of valganciclovir prophylaxis: therapeutic implications and outcomes publication-title: Clin Transplant – volume: 301 start-page: 1034 year: 2009 end-page: 1041 ident: bib104 article-title: Infections with oseltamivir-resistant influenza A(H1N1) virus in the United States publication-title: JAMA – volume: 24 start-page: 718 year: 1997 end-page: 722 ident: bib162 article-title: Treatment of Bolivian hemorrhagic fever with intravenous ribavirin publication-title: Clin Infect Dis – volume: 33 start-page: 167 year: 1999 end-page: 171 ident: bib50 article-title: Iritis associated with intravenous cidofovir publication-title: Ann Pharmacother – volume: 49 start-page: 1335 year: 2009 end-page: 1374 ident: bib130 article-title: Diagnosis, management, and treatment of hepatitis C: an update publication-title: Hepatology – volume: 343 start-page: 1673 year: 2000 end-page: 1680 ident: bib126 article-title: Peginterferon alfa-2a in patients with chronic hepatitis C and cirrhosis publication-title: N Engl J Med – volume: 28 start-page: 67 year: 2009 end-page: 71 ident: bib153 article-title: Efficacy of oral ribavirin in lung transplant patients with respiratory syncytial virus lower respiratory tract infection publication-title: J Heart Lung Transplant – volume: 166 start-page: 49 year: 2006 end-page: 56 ident: bib170 article-title: A double-blind placebo-controlled study of emtricitabine in chronic hepatitis B publication-title: Arch Intern Med – volume: 370 start-page: 2127 year: 2007 end-page: 2137 ident: bib4 article-title: Genital herpes publication-title: Lancet – volume: 21 start-page: 301 year: 2003 end-page: 309 ident: bib37 article-title: Topical cidofovir for the treatment of dermatologic conditions: verruca, condyloma, intraepithelial neoplasia, herpes simplex and its potential use in smallpox publication-title: Dermatol Clin – volume: 62 start-page: 710 year: 2006 end-page: 714 ident: bib148 article-title: Pharmacokinetics of ribavirin in patients with hepatitis C virus publication-title: Br J Clin Pharmacol – volume: 21 start-page: 267 year: 1999 end-page: 281 ident: bib106 article-title: Zanamivir: a review of clinical safety publication-title: Drug Saf – volume: 147 start-page: 745 year: 2007 end-page: 754 ident: bib183 article-title: Treatment of hepatitis B e antigen positive chronic hepatitis with telbivudine or adefovir: a randomized trial publication-title: Ann Intern Med – volume: 364 start-page: 1207 year: 2011 end-page: 1217 ident: bib196 article-title: Boceprevir for previously treated chronic HCV genotype 1 infection publication-title: N Engl J Med – volume: 47 start-page: 339 year: 2008 end-page: 345 ident: bib99 article-title: Comparison of the clinical effectiveness of oseltamivir and zanamivir against influenza virus infection in children publication-title: Clin Infect Dis – volume: 40 start-page: 2721 year: 1996 end-page: 2726 ident: bib59 article-title: Effect of foscarnet on quantities of cytomegalovirus and human immunodeficiency virus in blood of persons with AIDS publication-title: Antimicrob Agents Chemother – volume: 251 start-page: 2103 year: 1984 end-page: 2107 ident: bib5 article-title: Treatment of recurrent genital herpes simplex infections with oral acyclovir: a controlled trial publication-title: JAMA – volume: 117 start-page: 358 year: 1992 end-page: 363 ident: bib12 article-title: Treatment of adult varicella with oral acyclovir: a randomized, placebo-controlled trial publication-title: Ann Intern Med – volume: 16 start-page: 114 year: 2003 end-page: 128 ident: bib23 article-title: Herpes simplex virus resistance to acyclovir and penciclovir after two decades of antiviral therapy publication-title: Clin Microbiol Rev – volume: 3 start-page: 1561 year: 2002 end-page: 1566 ident: bib34 article-title: Role of cidofovir in the treatment of DNA virus infections, other than CMV infections, in immunocompromised patients publication-title: Curr Opin Investig Drugs – volume: 9 start-page: S104 year: 2009 end-page: S107 ident: bib8 article-title: Herpes simplex virus infections in solid organ transplant recipients publication-title: Am J Transplant – volume: 36 start-page: 1613 year: 2003 end-page: 1618 ident: bib161 article-title: The efficacy of oral ribavirin in the treatment of Crimean-Congo hemorrhagic fever in Iran publication-title: Clin Infect Dis – volume: 126 start-page: 1740 year: 2004 end-page: 1749 ident: bib120 article-title: Long-term benefit of interferon alpha therapy of chronic hepatitis D: regression of advanced hepatic fibrosis publication-title: Gastroenterology – volume: 148 start-page: 1757 year: 2003 end-page: 1769 ident: bib72 article-title: Profiling penciclovir susceptibility and prevalence of resistance of herpes simplex virus isolates across eleven clinical trials publication-title: Arch Virol – volume: 116 start-page: 633 year: 1990 end-page: 639 ident: bib11 article-title: Acyclovir treatment of varicella in otherwise healthy children publication-title: J Pediatr – volume: 314 start-page: 20 year: 1986 end-page: 26 ident: bib158 article-title: Lassa fever: effective therapy with ribavirin publication-title: N Engl J Med – volume: 4 start-page: 66 year: 2004 end-page: 71 ident: bib14 article-title: Other herpesviruses: HHV-6, HHV-7, HHV-8, HSV-1 and -2, VZV publication-title: Am J Transplant – volume: 50 start-page: 873 year: 1995 end-page: 896 ident: bib113 article-title: Interferon-alpha-2a: a review of its pharmacological properties and therapeutic use in the management of viral hepatitis publication-title: Drugs – start-page: CD000181 year: 2007 ident: bib152 article-title: Ribavirin for respiratory syncytial virus infection of the lower respiratory tract in infants and young children publication-title: Cochrane Database Syst Rev – volume: 344 start-page: 961 year: 2001 end-page: 966 ident: bib144 article-title: Paroxetine for the prevention of depression induced by high-dose interferon alfa publication-title: N Engl J Med – volume: 98 start-page: 914 year: 1983 end-page: 921 ident: bib1 article-title: Intravenous acyclovir for the treatment of primary genital herpes publication-title: Ann Intern Med – volume: 35 start-page: 371 year: 2004 end-page: 376 ident: bib10 article-title: Relapse of herpes encephalitis after acyclovir therapy: report of two new cases and review of the literature publication-title: Neuropediatrics – volume: 176 start-page: 119 year: 1992 end-page: 130 ident: bib96 article-title: Emergence and transmission of influenza A viruses resistant to amantadine and rimantadine publication-title: Curr Top Microbiol Immunol – volume: 156 start-page: 1729 year: 1996 end-page: 1735 ident: bib76 article-title: A large-scale, placebo-controlled, dose-ranging trial of peroral valaciclovir for episodic treatment of recurrent herpes genitalis publication-title: Arch Intern Med – volume: 7 start-page: 158 year: 2005 end-page: 161 ident: bib35 article-title: Treatment of verruca vulgaris with topical cidofovir in an immunocompromised patient: a case report and review of the literature publication-title: Transpl Infect Dis – volume: 41 start-page: 320 year: 2005 end-page: 326 ident: bib24 article-title: A retrospective, case-control study of acyclovir resistance in herpes simplex virus publication-title: Clin Infect Dis – volume: 55 start-page: i5 year: 2005 end-page: i21 ident: bib98 article-title: Oseltamivir (Tamiflu) and its potential for use in the event of an influenza pandemic publication-title: J Antimicrob Chemother – volume: 1 start-page: 242 year: 1983 end-page: 243 ident: bib21 article-title: Megaloblastic haemopoiesis due to acyclovir publication-title: Lancet – volume: 59 start-page: 827 year: 2007 end-page: 832 ident: bib169 article-title: Progress in the treatment of chronic hepatitis B: long-term experience with adefovir dipivoxil publication-title: J Antimicrob Chemother – volume: 43 start-page: 595 year: 2004 end-page: 612 ident: bib184 article-title: Tenofovir disoproxil fumarate: clinical pharmacology and pharmacokinetics publication-title: Clin Pharmacokinet – volume: 106 start-page: 459 year: 1999 end-page: 465 ident: bib16 article-title: Crystal-induced acute renal failure publication-title: Am J Med – volume: 351 start-page: 438 year: 2004 end-page: 450 ident: bib132 article-title: Peginterferon Alfa-2a plus ribavirin for chronic hepatitis C virus infection in HIV-infected patients publication-title: N Engl J Med – volume: 132 start-page: 1767 year: 2007 end-page: 1777 ident: bib198 article-title: Dynamic hepatitis C virus genotypic and phenotypic changes in patients treated with the protease inhibitor telaprevir publication-title: Gastroenterology – volume: 57 start-page: 8 year: 2006 end-page: 13 ident: bib150 article-title: Treating HCV with ribavirin analogues and ribavirin-like molecules publication-title: J Antimicrob Chemother – volume: 49 start-page: 233 year: 2009 end-page: 240 ident: bib46 article-title: Cidofovir for BK virus-associated hemorrhagic cystitis: a retrospective study publication-title: Clin Infect Dis – volume: 37 start-page: 1139 year: 2003 end-page: 1142 ident: bib154 article-title: Common adverse events associated with the use of ribavirin for severe acute respiratory syndrome in Canada publication-title: Clin Infect Dis – volume: 351 start-page: 1206 year: 2004 end-page: 1217 ident: bib117 article-title: Peginterferon alfa-2a alone, lamivudine alone, and the two in combination in patients with HBeAg-negative chronic hepatitis B publication-title: N Engl J Med – volume: 60 start-page: 193 year: 2007 end-page: 194 ident: bib48 article-title: Simultaneous development of Fanconi syndrome and acute renal failure associated with cidofovir publication-title: J Antimicrob Chemother – volume: 36 start-page: 41 year: 1999 end-page: 66 ident: bib174 article-title: Clinical pharmacokinetics of lamivudine publication-title: Clin Pharmacokinet – volume: 49 start-page: 810 year: 2001 end-page: 813 ident: bib157 article-title: Treatment of acute Nipah encephalitis with ribavirin publication-title: Ann Neurol – volume: 133 start-page: 467 year: 2002 end-page: 474 ident: bib56 article-title: A randomized controlled clinical trial of intravitreous fomivirsen for treatment of newly diagnosed peripheral cytomegalovirus retinitis in patients with AIDS publication-title: Am J Ophthalmol – volume: 9 start-page: S108 year: 2009 end-page: S115 ident: bib77 article-title: Varicella zoster virus (VZV) in solid organ transplant recipients publication-title: Am J Transplant – volume: 27 start-page: 494 year: 2007 end-page: 503 ident: bib155 article-title: Adverse events associated with high-dose ribavirin: evidence from the Toronto outbreak of severe acute respiratory syndrome publication-title: Pharmacotherapy – reference: . doi:10.1345/aph.1P744. – volume: 8 start-page: 651 year: 2002 end-page: 658 ident: bib67 article-title: The impact of human herpesvirus-6 and -7 infection on the outcome of liver transplantation publication-title: Liver Transpl – volume: 37 start-page: 849 year: 2003 end-page: 859 ident: bib185 article-title: Tenofovir disoproxil fumarate publication-title: Ann Pharmacother – volume: 26 start-page: 1745 year: 2006 end-page: 1757 ident: bib171 article-title: Entecavir: a new nucleoside analog for the treatment of chronic hepatitis B infection publication-title: Pharmacotherapy – volume: 340 start-page: 1462 year: 1999 end-page: 1470 ident: bib78 article-title: Valacyclovir for the prevention of cytomegalovirus disease after renal transplantation publication-title: N Engl J Med – volume: 2 start-page: 2740 year: 2010 end-page: 2762 ident: bib28 article-title: Development of CMX001 for the treatment of poxvirus infections publication-title: Viruses – volume: 49 start-page: 725 year: 2009 end-page: 734 ident: bib179 article-title: Population pharmacokinetics of telbivudine and determination of dose adjustment for patients with renal impairment publication-title: J Clin Pharmacol – volume: 29 start-page: 31 year: 1998 ident: bib57 article-title: Fomivirsen publication-title: BETA – volume: 315 start-page: 1059 year: 1986 end-page: 1064 ident: bib136 article-title: Interferon therapy for condylomata acuminata publication-title: N Engl J Med – volume: 39 start-page: 1724 year: 2004 end-page: 1729 ident: bib142 article-title: Spectrum of pulmonary toxicity associated with the use of interferon therapy for hepatitis C: case report and review of the literature publication-title: Clin Infect Dis – volume: 150 start-page: 1 year: 1984 end-page: 6 ident: bib6 article-title: A collaborative study of patient-initiated treatment of recurrent genital herpes with topical acyclovir or placebo publication-title: J Infect Dis – volume: 68 start-page: 2301 year: 2004 end-page: 2315 ident: bib26 article-title: Discovery and development of BVDU (brivudin) as a therapeutic for the treatment of herpes zoster publication-title: Biochem Pharmacol – volume: 80 start-page: 77 year: 2007 end-page: 81 ident: bib53 article-title: Famciclovir for cutaneous herpesvirus infections: an update and review of new single-day dosing indications publication-title: Cutis – volume: 4 start-page: 304 year: 1989 end-page: 310 ident: bib93 article-title: Amantadine and rimantadine for the prevention of influenza A publication-title: Semin Respir Infect – volume: 346 start-page: 1119 year: 2002 end-page: 1126 ident: bib83 article-title: A controlled trial of valganciclovir as induction therapy for cytomegalovirus retinitis publication-title: N Engl J Med – volume: 292 start-page: 2839 year: 2004 end-page: 2848 ident: bib131 article-title: Pegylated interferon alfa-2b vs standard interferon alfa-2b, plus ribavirin, for chronic hepatitis C in HIV-infected patients: a randomized controlled trial publication-title: JAMA – volume: 99 start-page: 261 year: 1997 end-page: 267 ident: bib156 article-title: Treatment of severe La Crosse encephalitis with intravenous ribavirin following diagnosis by brain biopsy publication-title: Pediatrics – volume: 2 start-page: 571 year: 1982 end-page: 573 ident: bib2 article-title: Efficacy of oral acyclovir in the treatment of initial and recurrent genital herpes publication-title: Lancet – volume: 46 start-page: 28 year: 2008 end-page: 29 ident: bib86 article-title: Use of valganciclovir for prevention and treatment of cytomegalovirus disease [editorial] publication-title: Clin Infect Dis – volume: 360 start-page: 1827 year: 2009 end-page: 1838 ident: bib199 article-title: Telaprevir with peginterferon and ribavirin for chronic HCV genotype 1 infection publication-title: N Engl J Med – volume: 170 start-page: 570 year: 1994 end-page: 572 ident: bib38 article-title: Treatment with intravenous (S)-1-[3-hydroxy-2-(phosphonylmethoxy)propyl]-cytosine of acyclovir-resistant mucocutaneous infection with herpes simplex virus in a patient with AIDS publication-title: J Infect Dis – volume: 352 start-page: 2673 year: 2005 end-page: 2681 ident: bib168 article-title: Long-term therapy with adefovir dipivoxil for HBeAg-negative chronic hepatitis B publication-title: N Engl J Med – volume: 52 start-page: 225 year: 1996 end-page: 230 ident: bib27 article-title: Cidofovir publication-title: Drugs – volume: 341 start-page: 1256 year: 1999 end-page: 1263 ident: bib176 article-title: Lamivudine as initial treatment for chronic hepatitis B in the United States publication-title: N Engl J Med – volume: 365 start-page: 123 year: 2005 end-page: 129 ident: bib118 article-title: Pegylated Interferon alfa-2b alone or in combination with lamivudine for HBeAg-positive chronic hepatitis B: a randomised trial publication-title: Lancet – volume: 259 start-page: 1566 year: 1984 end-page: 1569 ident: bib66 article-title: Interaction of herpes simplex virus-induced DNA polymerase with 9-(1,3-dihydroxy-2-propoxymethyl)guanine triphosphate publication-title: J Biol Chem – volume: 40 start-page: 472 year: 2006 end-page: 478 ident: bib180 article-title: Telbivudine: a novel nucleoside analog for chronic hepatitis B publication-title: Ann Pharmacother – volume: 37 start-page: 167 year: 1999 end-page: 176 ident: bib80 article-title: Pharmacokinetics of valganciclovir and ganciclovir following multiple oral dosages of valganciclovir in HIV- and CMV-seropositive volunteers publication-title: Clin Pharmacokinet – volume: 61 start-page: 2263 year: 2001 end-page: 2288 ident: bib125 article-title: Peginterferon-alpha-2a (40 kD): a review of its use in the management of chronic hepatitis C publication-title: Drugs – volume: 31 start-page: 185 year: 1997 end-page: 191 ident: bib75 article-title: Valacyclovir publication-title: Ann Pharmacother – volume: 83 start-page: 1153 year: 1999 end-page: 1158 ident: bib49 article-title: Anterior uveitis associated with intravenous cidofovir use in patients with cytomegalovirus retinitis publication-title: Br J Ophthalmol – volume: 168 start-page: 444 year: 1993 end-page: 448 ident: bib62 article-title: A dose-ranging study of daily maintenance intravenous foscarnet therapy for cytomegalovirus retinitis in AIDS publication-title: J Infect Dis – volume: 53 start-page: 4816 year: 2009 end-page: 4824 ident: bib82 article-title: Population pharmacokinetics of ganciclovir after intravenous ganciclovir and oral valganciclovir administration in solid organ transplant patients infected with cytomegalovirus publication-title: Antimicrob Agents Chemother – volume: 437 start-page: 1108 year: 2005 ident: bib103 article-title: Avian flu: isolation of drug-resistant H5N1 virus publication-title: Nature – volume: 32 start-page: 111 year: 1998 end-page: 113 ident: bib18 article-title: Acyclovir- and ganciclovir-induced neurotoxicity publication-title: Ann Pharmacother – volume: 20 start-page: 1083 year: 2001 end-page: 1086 ident: bib39 article-title: Successful treatment of foscarnet-resistant herpes simplex stomatitis with intravenous cidofovir in a child publication-title: Pediatr Infect Dis J – volume: 7 start-page: 353 year: 2001 end-page: 357 ident: bib139 article-title: The relative contributions of HAART and alpha-interferon for therapy of progressive multifocal leukoencephalopathy in AIDS publication-title: J Neurovirol – volume: 347 start-page: 975 year: 2002 end-page: 982 ident: bib128 article-title: Peginterferon alfa-2a plus ribavirin for chronic hepatitis C virus infection publication-title: N Engl J Med – volume: 147 start-page: 134 year: 2002 end-page: 138 ident: bib40 article-title: Successful treatment of an aciclovir-resistant herpes simplex type 2 infection with cidofovir in an AIDS patient publication-title: Br J Dermatol – volume: 350 start-page: 1729 year: 1997 end-page: 1733 ident: bib70 article-title: Randomised trial of efficacy and safety of oral ganciclovir in the prevention of cytomegalovirus disease in liver-transplant recipients [published correction appears in publication-title: Lancet – volume: 43 start-page: 43 year: 2003 end-page: 51 ident: bib29 article-title: Pharmacokinetics and renal effects of cidofovir with a reduced dose of probenecid in HIV-infected patients with cytomegalovirus retinitis publication-title: J Clin Pharmacol – volume: 27 start-page: 1458 year: 1993 end-page: 1459 ident: bib20 article-title: Vesicular eruptions following acyclovir administration publication-title: Ann Pharmacother – volume: 24 start-page: 778 year: 1996 end-page: 789 ident: bib123 article-title: Meta-analysis of interferon randomized trials in the treatment of viral hepatitis C: effects of dose and duration publication-title: Hepatology – volume: 339 start-page: 61 year: 1998 end-page: 68 ident: bib177 article-title: A one-year trial of lamivudine for chronic hepatitis B publication-title: N Engl J Med – volume: 330 start-page: 88 year: 1994 end-page: 94 ident: bib119 article-title: Treatment of chronic hepatitis D with interferon alfa-2a publication-title: N Engl J Med – reference: Foote BC, Spooner LM, Belliveau PP. Boceprevir: a protease inhibitor for the treatment of chronic hepatitis C [Epub ahead of print August 9, 2011]. – volume: 50 start-page: 661 year: 2009 end-page: 662 ident: bib114 article-title: Chronic hepatitis B: update 2009 publication-title: Hepatology – volume: 76 start-page: 1171 year: 2001 end-page: 1175 ident: bib43 article-title: Cidofovir treatment of progressive multifocal leukoencephalopathy in a patient receiving highly active antiretroviral therapy publication-title: Mayo Clin Proc – volume: 348 start-page: 800 year: 2003 end-page: 807 ident: bib167 article-title: Adefovir dipivoxil for the treatment of hepatitis B e antigen-negative chronic hepatitis B publication-title: N Engl J Med – volume: 35 start-page: 33 year: 2007 end-page: 36 ident: bib45 article-title: Improvement of progressive multifocal leukoencephalopathy after cidofovir therapy in a patient with a destructive polyarthritis publication-title: Infection – volume: 44 start-page: 309 year: 2006 end-page: 313 ident: bib187 article-title: Tenofovir disoproxil fumarate: role in hepatitis B treatment publication-title: Hepatology – volume: 38 start-page: 2454 year: 1994 end-page: 2457 ident: bib54 article-title: Safety of famciclovir in patients with herpes zoster and genital herpes publication-title: Antimicrob Agents Chemother – volume: 15 start-page: 900 year: 2008 end-page: 911 ident: bib25 article-title: New advances in anti-HSV chemotherapy publication-title: Curr Med Chem – volume: 42 start-page: 2240 year: 1998 end-page: 2244 ident: bib33 article-title: Incidence of foscarnet resistance and cidofovir resistance in patients treated for cytomegalovirus retinitis publication-title: Antimicrob Agents Chemother – volume: 364 start-page: 1195 year: 2011 end-page: 1206 ident: bib195 article-title: Boceprevir for untreated chronic HCV genotype 1 infection publication-title: N Engl J Med – volume: 346 start-page: 472 year: 1995 end-page: 475 ident: bib160 article-title: Crimean Congo-haemorrhagic fever treated with oral ribavirin publication-title: Lancet – volume: 48 start-page: 383 year: 2008 end-page: 386 ident: bib188 article-title: Potency of tenofovir in chronic hepatitis B: mono or combination therapy? publication-title: J Hepatol – volume: 374 start-page: 1036 year: 2009 ident: bib108 article-title: H1N1 pneumonitis treated with intravenous zanamivir publication-title: Lancet – volume: 348 start-page: 808 year: 2003 end-page: 816 ident: bib166 article-title: Adefovir dipivoxil for the treatment of hepatitis B e antigen-positive chronic hepatitis B publication-title: N Engl J Med – volume: 60 start-page: 1295 year: 2006 end-page: 1299 ident: bib181 article-title: Novel anti-hepatitis B agents: a focus on telbivudine publication-title: Int J Clin Pract – volume: 13 start-page: 1001 year: 2008 end-page: 1009 ident: bib36 article-title: Low-dose cidofovir for the treatment of polyomavirus-associated nephropathy: two case reports and review of the literature publication-title: Antivir Ther – volume: 364 start-page: 2405 year: 2011 end-page: 2416 ident: bib201 article-title: Telaprevir for previously untreated chronic hepatitis C virus infection publication-title: N Engl J Med – volume: 16 start-page: 25 year: 2000 end-page: 40 ident: bib65 article-title: Recent advances in the therapy and prevention of CMV infections publication-title: J Clin Virol – volume: 336 start-page: 755 year: 1990 ident: bib63 article-title: Foscarnet and crystals in glomerular capillary lumens publication-title: Lancet – volume: 37 start-page: 245 year: 2001 end-page: 255 ident: bib55 article-title: Fomivirsen publication-title: Drugs Today (Barc) – volume: 22 start-page: 99 year: 2008 end-page: 103 ident: bib190 article-title: Tenofovir-associated Fanconi syndrome: review of the FDA adverse event reporting system publication-title: AIDS Patient Care STDS – volume: 151 start-page: 464 year: 2009 end-page: 473 ident: bib100 article-title: Systematic review: safety and efficacy of extended-duration antiviral chemoprophylaxis against pandemic and seasonal influenza publication-title: Ann Intern Med – volume: 37 start-page: 944 year: 2003 end-page: 950 ident: bib186 article-title: Tenofovir disoproxil fumarate publication-title: Clin Infect Dis – volume: 9 start-page: S78 year: 2009 end-page: S86 ident: bib61 article-title: Cytomegalovirus in solid organ transplant recipients publication-title: Am J Transplant – volume: 36 start-page: 127 year: 1999 end-page: 143 ident: bib30 article-title: Clinical pharmacokinetics of the antiviral nucleotide analogues cidofovir and adefovir publication-title: Clin Pharmacokinet – volume: 42 start-page: 615 year: 2005 end-page: 624 ident: bib122 article-title: Short statement of the first European Consensus Conference on the treatment of chronic hepatitis B and C in HIV co-infected patients publication-title: J Hepatol – volume: 329 start-page: 1744 year: 1993 ident: bib163 article-title: Hantavirus-associated acute respiratory failure publication-title: N Engl J Med – volume: 35 start-page: 741 year: 2001 end-page: 744 ident: bib44 article-title: Use of cidofovir in progressive multifocal leukoencephalopathy publication-title: Ann Pharmacother – volume: 164 start-page: 1119 year: 1991 end-page: 1127 ident: bib159 article-title: Prospective, double-blind, concurrent, placebo-controlled clinical trial of intravenous ribavirin therapy of hemorrhagic fever with renal syndrome publication-title: J Infect Dis – volume: 44 start-page: 495 year: 2005 end-page: 507 ident: bib81 article-title: Pharmacokinetic profile of ganciclovir after its oral administration and from its prodrug, valganciclovir, in solid organ transplant recipients publication-title: Clin Pharmacokinet – volume: 12 start-page: 333 year: 2005 end-page: 345 ident: bib115 article-title: Treatment of chronic hepatitis B publication-title: J Viral Hepat – volume: 42 start-page: 329 year: 2005 end-page: 333 ident: bib135 article-title: Efficacy of a 24-week course of PEG-interferon alpha-2b monotherapy in patients with acute hepatitis C after failure of spontaneous clearance publication-title: J Hepatol – volume: 333 start-page: 615 year: 1995 end-page: 620 ident: bib69 article-title: Oral ganciclovir as maintenance treatment for cytomegalovirus retinitis in patients with AIDS publication-title: N Engl J Med – volume: 2 start-page: 94 year: 2008 ident: bib192 article-title: Acute renal failure in an AIDS patient on tenofovir: a case report publication-title: J Med Case Reports – volume: 358 start-page: 958 year: 2001 end-page: 965 ident: bib129 article-title: Peginterferon alfa-2b plus ribavirin compared with interferon alfa-2b plus ribavirin for initial treatment of chronic hepatitis C: a randomised trial publication-title: Lancet – volume: 338 start-page: 1268 year: 1991 end-page: 1269 ident: bib145 article-title: Liver failure due to recombinant alpha interferon publication-title: Lancet – volume: 119 start-page: 312 year: 1993 end-page: 323 ident: bib112 article-title: Effect of alpha-interferon treatment in patients with hepatitis B e antigen-positive chronic hepatitis B: a meta-analysis publication-title: Ann Intern Med – volume: 147 start-page: 1577 year: 1987 end-page: 1580 ident: bib140 article-title: Psychiatric complications of long-term interferon alfa therapy publication-title: Arch Intern Med – volume: 19 start-page: 221 year: 2005 end-page: 240 ident: bib121 article-title: Care of patients with chronic hepatitis B and HIV co-infection: recommendations from an HIV-HBV International Panel publication-title: AIDS – volume: 107 start-page: 3002 year: 2006 end-page: 3008 ident: bib87 article-title: Oral valganciclovir leads to higher exposure to ganciclovir than intravenous ganciclovir in patients following allogeneic stem cell transplantation publication-title: Blood – volume: 157 start-page: 867 year: 2000 end-page: 876 ident: bib141 article-title: Neuropsychiatric symptoms associated with hepatitis C and interferon19 alpha: a review publication-title: Am J Psychiatry – volume: 7 start-page: 2106 year: 2007 end-page: 2113 ident: bib89 article-title: Oral valganciclovir is noninferior to intravenous ganciclovir for the treatment of cytomegalovirus disease in solid organ transplant recipients publication-title: Am J Transplant – volume: 277 start-page: 1374 year: 1997 end-page: 1379 ident: bib74 article-title: Penciclovir cream for the treatment of herpes simplex labialis: a randomized, multicenter, double-blind, placebo-controlled trial publication-title: JAMA – volume: 38 start-page: 625 year: 2004 end-page: 633 ident: bib165 article-title: Adefovir dipivoxil in the treatment of chronic hepatitis B publication-title: Ann Pharmacother – volume: 42 start-page: 283 year: 2006 end-page: 290 ident: bib193 article-title: Tenofovir-associated acute and chronic kidney disease: a case of multiple drug interactions publication-title: Clin Infect Dis – volume: 32 start-page: 1181 year: 1998 end-page: 1192 ident: bib31 article-title: Cidofovir in the treatment of cytomegaloviral disease publication-title: Ann Pharmacother – volume: 205 start-page: 300 year: 2002 end-page: 301 ident: bib147 article-title: Alopecia areata during interferon alpha-2b/ribavirin therapy publication-title: Dermatology – volume: 44 start-page: 91 year: 2009 end-page: 93 ident: bib95 article-title: Differential patterns of amantadine-resistance in influenza A (H3N2) and (H1N1) isolates in Toronto, Canada publication-title: J Clin Virol – volume: 353 start-page: 2667 year: 2005 end-page: 2672 ident: bib102 article-title: Oseltamivir resistance during treatment of influenza A (H5N1) infection publication-title: N Engl J Med – start-page: CD005445 year: 2010 ident: bib127 article-title: Ribavirin plus interferon versus interferon for chronic hepatitis C publication-title: Cochrane Database Syst Rev – volume: 132 start-page: 1979 year: 2007 end-page: 1998 ident: bib197 article-title: The hepatitis C virus life cycle as a target for new antiviral therapies publication-title: Gastroenterology – volume: 168 start-page: 557 year: 1993 end-page: 563 ident: bib68 article-title: A randomized, controlled study of intravenous ganciclovir therapy for cytomegalovirus peripheral retinitis in patients with AIDS publication-title: J Infect Dis – volume: 297 start-page: 1435 year: 2007 end-page: 1442 ident: bib105 article-title: Emergence of influenza B viruses with reduced sensitivity to neuraminidase inhibitors publication-title: JAMA – volume: 16 start-page: 1791 year: 2002 end-page: 1797 ident: bib42 article-title: A pilot study of cidofovir for progressive multifocal leukoencephalopathy in AIDS publication-title: AIDS – volume: 30 start-page: 115 year: 2004 end-page: 133 ident: bib91 article-title: Antiviral drugs in current clinical use publication-title: J Clin Virol – volume: 345 start-page: 1452 year: 2001 end-page: 1457 ident: bib134 article-title: Treatment of acute hepatitis C with interferon alfa-2b publication-title: N Engl J Med – volume: 6 start-page: 155 year: 2007 end-page: 164 ident: bib189 article-title: Tenofovir-induced kidney injury publication-title: Expert Opin Drug Saf – volume: 20 start-page: 791 year: 2006 end-page: 793 ident: bib41 article-title: Progressive multifocal leukoencephalopathy: prolonged survival in patients treated with protease inhibitors and cidofovir: a case series publication-title: AIDS – volume: 364 start-page: 2417 year: 2011 end-page: 2428 ident: bib202 article-title: Telaprevir for retreatment of HCV infection publication-title: N Engl J Med – volume: 57 start-page: 945 year: 2006 end-page: 949 ident: bib17 article-title: The aciclovir metabolite CMMG is detectable in the CSF of subjects with neuropsychiatric symptoms during aciclovir and valaciclovir treatment publication-title: J Antimicrob Chemother – volume: 333 start-page: 1657 year: 1995 end-page: 1661 ident: bib175 article-title: A preliminary trial of lamivudine for chronic hepatitis B infection publication-title: N Engl J Med – volume: 63 start-page: 2215 year: 2003 end-page: 2234 ident: bib164 article-title: Adefovir dipivoxil: a review of its use in chronic hepatitis B publication-title: Drugs – volume: 346 start-page: 1156 year: 1995 end-page: 1157 ident: bib178 article-title: Hepatitis B reactivation after lamivudine publication-title: Lancet – volume: 23 start-page: 19 year: 2003 end-page: 22 ident: bib111 article-title: Pegylation of interferon alfa: structural and pharmacokinetic properties publication-title: Semin Liver Dis – volume: 343 start-page: 1666 year: 2000 end-page: 1672 ident: bib124 article-title: Peginterferon alfa-2a in patients with chronic hepatitis C publication-title: N Engl J Med – volume: 310 start-page: 32 year: 1984 end-page: 35 ident: bib146 article-title: Acute interstitial nephritis with the nephrotic syndrome following recombinant leukocyte a interferon therapy for mycosis fungoides publication-title: N Engl J Med – volume: 13 start-page: 1 year: 2009 end-page: 246 ident: bib92 article-title: Amantadine, oseltamivir and zanamivir for the prophylaxis of influenza (including a review of existing guidance no. 67): a systematic review and economic evaluation publication-title: Health Technol Assess – volume: 24 start-page: 1113 year: 2001 end-page: 1125 ident: bib109 article-title: Zanamivir: a review of clinical safety in individuals at high risk of developing influenza-related complications publication-title: Drug Saf – volume: 23 start-page: 23 year: 2003 end-page: 28 ident: bib110 article-title: Pharmacokinetics of peginterferons publication-title: Semin Liver Dis – volume: 89 start-page: 779 year: 2010 end-page: 795 ident: bib60 article-title: International consensus guidelines on the management of cytomegalovirus in solid organ transplantation publication-title: Transplantation – volume: 247 start-page: 2132 year: 1982 ident: 10.4065/mcp.2011.0309_bib3 article-title: Acyclovir treatment of herpes zoster infections: use in children undergoing bone marrow transplantation publication-title: JAMA doi: 10.1001/jama.1982.03320400044032 – volume: 6 start-page: 155 year: 2007 ident: 10.4065/mcp.2011.0309_bib189 article-title: Tenofovir-induced kidney injury publication-title: Expert Opin Drug Saf doi: 10.1517/14740338.6.2.155 – volume: 49 start-page: 233 year: 2009 ident: 10.4065/mcp.2011.0309_bib46 article-title: Cidofovir for BK virus-associated hemorrhagic cystitis: a retrospective study publication-title: Clin Infect Dis doi: 10.1086/599829 – volume: 35 start-page: 33 year: 2007 ident: 10.4065/mcp.2011.0309_bib45 article-title: Improvement of progressive multifocal leukoencephalopathy after cidofovir therapy in a patient with a destructive polyarthritis publication-title: Infection doi: 10.1007/s15010-006-5103-y – volume: 151 start-page: 362 year: 1985 ident: 10.4065/mcp.2011.0309_bib15 article-title: Adverse effects of high-dose intravenous acyclovir in ambulatory patients with acute herpes zoster publication-title: J Infect Dis doi: 10.1093/infdis/151.2.362 – volume: 53 start-page: 4816 year: 2009 ident: 10.4065/mcp.2011.0309_bib82 article-title: Population pharmacokinetics of ganciclovir after intravenous ganciclovir and oral valganciclovir administration in solid organ transplant patients infected with cytomegalovirus publication-title: Antimicrob Agents Chemother doi: 10.1128/AAC.00085-09 – volume: 4 start-page: 304 year: 1989 ident: 10.4065/mcp.2011.0309_bib93 article-title: Amantadine and rimantadine for the prevention of influenza A publication-title: Semin Respir Infect – volume: 314 start-page: 20 year: 1986 ident: 10.4065/mcp.2011.0309_bib158 article-title: Lassa fever: effective therapy with ribavirin publication-title: N Engl J Med doi: 10.1056/NEJM198601023140104 – volume: 176 start-page: 119 year: 1992 ident: 10.4065/mcp.2011.0309_bib96 article-title: Emergence and transmission of influenza A viruses resistant to amantadine and rimantadine publication-title: Curr Top Microbiol Immunol – volume: 370 start-page: 2127 year: 2007 ident: 10.4065/mcp.2011.0309_bib4 article-title: Genital herpes publication-title: Lancet doi: 10.1016/S0140-6736(07)61908-4 – volume: 107 start-page: 3002 year: 2006 ident: 10.4065/mcp.2011.0309_bib87 article-title: Oral valganciclovir leads to higher exposure to ganciclovir than intravenous ganciclovir in patients following allogeneic stem cell transplantation publication-title: Blood doi: 10.1182/blood-2005-09-3786 – volume: 351 start-page: 1206 year: 2004 ident: 10.4065/mcp.2011.0309_bib117 article-title: Peginterferon alfa-2a alone, lamivudine alone, and the two in combination in patients with HBeAg-negative chronic hepatitis B publication-title: N Engl J Med doi: 10.1056/NEJMoa040431 – volume: 104 start-page: 2335 year: 2009 ident: 10.4065/mcp.2011.0309_bib151 article-title: Peginterferon plus ribavirin for chronic hepatitis C in patients with human immunodeficiency virus publication-title: Am J Gastroenterol doi: 10.1038/ajg.2009.311 – volume: 24 start-page: 778 year: 1996 ident: 10.4065/mcp.2011.0309_bib123 article-title: Meta-analysis of interferon randomized trials in the treatment of viral hepatitis C: effects of dose and duration publication-title: Hepatology doi: 10.1002/hep.510240405 – volume: 41 start-page: 320 year: 2005 ident: 10.4065/mcp.2011.0309_bib24 article-title: A retrospective, case-control study of acyclovir resistance in herpes simplex virus publication-title: Clin Infect Dis doi: 10.1086/431585 – volume: 344 start-page: 961 year: 2001 ident: 10.4065/mcp.2011.0309_bib144 article-title: Paroxetine for the prevention of depression induced by high-dose interferon alfa publication-title: N Engl J Med doi: 10.1056/NEJM200103293441303 – volume: 42 start-page: 615 year: 2005 ident: 10.4065/mcp.2011.0309_bib122 article-title: Short statement of the first European Consensus Conference on the treatment of chronic hepatitis B and C in HIV co-infected patients publication-title: J Hepatol doi: 10.1016/j.jhep.2005.03.003 – volume: 20 start-page: 791 year: 2006 ident: 10.4065/mcp.2011.0309_bib41 article-title: Progressive multifocal leukoencephalopathy: prolonged survival in patients treated with protease inhibitors and cidofovir: a case series publication-title: AIDS doi: 10.1097/01.aids.0000216390.83351.87 – volume: 19 start-page: 221 year: 2005 ident: 10.4065/mcp.2011.0309_bib121 article-title: Care of patients with chronic hepatitis B and HIV co-infection: recommendations from an HIV-HBV International Panel publication-title: AIDS doi: 10.1097/01.aids.0000163948.62176.e7 – volume: 43 start-page: 595 year: 2004 ident: 10.4065/mcp.2011.0309_bib184 article-title: Tenofovir disoproxil fumarate: clinical pharmacology and pharmacokinetics publication-title: Clin Pharmacokinet doi: 10.2165/00003088-200443090-00003 – volume: 22 start-page: 162 year: 2008 ident: 10.4065/mcp.2011.0309_bib71 article-title: Emergence of drug-resistant cytomegalovirus in the era of valganciclovir prophylaxis: therapeutic implications and outcomes publication-title: Clin Transplant doi: 10.1111/j.1399-0012.2007.00761.x – volume: 36 start-page: 127 year: 1999 ident: 10.4065/mcp.2011.0309_bib30 article-title: Clinical pharmacokinetics of the antiviral nucleotide analogues cidofovir and adefovir publication-title: Clin Pharmacokinet doi: 10.2165/00003088-199936020-00004 – volume: 346 start-page: 472 year: 1995 ident: 10.4065/mcp.2011.0309_bib160 article-title: Crimean Congo-haemorrhagic fever treated with oral ribavirin publication-title: Lancet doi: 10.1016/S0140-6736(95)91323-8 – volume: 164 start-page: 1119 year: 1991 ident: 10.4065/mcp.2011.0309_bib159 article-title: Prospective, double-blind, concurrent, placebo-controlled clinical trial of intravenous ribavirin therapy of hemorrhagic fever with renal syndrome publication-title: J Infect Dis doi: 10.1093/infdis/164.6.1119 – volume: 2 start-page: 2740 year: 2010 ident: 10.4065/mcp.2011.0309_bib28 article-title: Development of CMX001 for the treatment of poxvirus infections publication-title: Viruses doi: 10.3390/v2122740 – volume: 7 start-page: 353 year: 2001 ident: 10.4065/mcp.2011.0309_bib139 article-title: The relative contributions of HAART and alpha-interferon for therapy of progressive multifocal leukoencephalopathy in AIDS publication-title: J Neurovirol doi: 10.1080/13550280152537238 – volume: 37 start-page: 944 year: 2003 ident: 10.4065/mcp.2011.0309_bib186 article-title: Tenofovir disoproxil fumarate publication-title: Clin Infect Dis doi: 10.1086/378068 – volume: 43 start-page: 43 year: 2003 ident: 10.4065/mcp.2011.0309_bib29 article-title: Pharmacokinetics and renal effects of cidofovir with a reduced dose of probenecid in HIV-infected patients with cytomegalovirus retinitis publication-title: J Clin Pharmacol doi: 10.1177/0091270002239705 – volume: 46 start-page: 20 year: 2008 ident: 10.4065/mcp.2011.0309_bib88 article-title: Valganciclovir as treatment for cytomegalovirus disease in solid organ transplant recipients publication-title: Clin Infect Dis doi: 10.1086/523590 – volume: 44 start-page: 91 year: 2009 ident: 10.4065/mcp.2011.0309_bib95 article-title: Differential patterns of amantadine-resistance in influenza A (H3N2) and (H1N1) isolates in Toronto, Canada publication-title: J Clin Virol doi: 10.1016/j.jcv.2008.10.001 – volume: 21 start-page: 267 year: 1999 ident: 10.4065/mcp.2011.0309_bib106 article-title: Zanamivir: a review of clinical safety publication-title: Drug Saf doi: 10.2165/00002018-199921040-00003 – volume: 50 start-page: 661 year: 2009 ident: 10.4065/mcp.2011.0309_bib114 article-title: Chronic hepatitis B: update 2009 publication-title: Hepatology doi: 10.1002/hep.23190 – volume: 28 start-page: 1035 year: 1994 ident: 10.4065/mcp.2011.0309_bib64 article-title: Neurologic sequelae associated with foscarnet therapy publication-title: Ann Pharmacother doi: 10.1177/106002809402800908 – volume: 90 start-page: 900 year: 2009 ident: 10.4065/mcp.2011.0309_bib94 article-title: High prevalence of amantadine resistance among circulating European porcine influenza A viruses publication-title: J Gen Virol doi: 10.1099/vir.2008.007260-0 – volume: 151 start-page: 464 year: 2009 ident: 10.4065/mcp.2011.0309_bib100 article-title: Systematic review: safety and efficacy of extended-duration antiviral chemoprophylaxis against pandemic and seasonal influenza publication-title: Ann Intern Med doi: 10.7326/0003-4819-151-7-200910060-00143 – volume: 2 start-page: 27 year: 2004 ident: 10.4065/mcp.2011.0309_bib79 article-title: Valganciclovir for the prevention and treatment of cytomegalovirus disease in immunocompromised hosts publication-title: Expert Rev Anti Infect Ther doi: 10.1586/14787210.2.1.27 – volume: 16 start-page: 1791 year: 2002 ident: 10.4065/mcp.2011.0309_bib42 article-title: A pilot study of cidofovir for progressive multifocal leukoencephalopathy in AIDS publication-title: AIDS doi: 10.1097/00002030-200209060-00012 – volume: 333 start-page: 1657 year: 1995 ident: 10.4065/mcp.2011.0309_bib175 article-title: A preliminary trial of lamivudine for chronic hepatitis B infection publication-title: N Engl J Med doi: 10.1056/NEJM199512213332501 – volume: 35 start-page: 1741 year: 1991 ident: 10.4065/mcp.2011.0309_bib97 article-title: Recovery of drug-resistant influenza A virus during therapeutic use of rimantadine publication-title: Antimicrob Agents Chemother doi: 10.1128/AAC.35.9.1741 – volume: 340 start-page: 1462 year: 1999 ident: 10.4065/mcp.2011.0309_bib78 article-title: Valacyclovir for the prevention of cytomegalovirus disease after renal transplantation publication-title: N Engl J Med doi: 10.1056/NEJM199905133401903 – volume: 24 start-page: 718 year: 1997 ident: 10.4065/mcp.2011.0309_bib162 article-title: Treatment of Bolivian hemorrhagic fever with intravenous ribavirin publication-title: Clin Infect Dis doi: 10.1093/clind/24.4.718 – volume: 329 start-page: 1744 year: 1993 ident: 10.4065/mcp.2011.0309_bib163 article-title: Hantavirus-associated acute respiratory failure publication-title: N Engl J Med doi: 10.1056/NEJM199312023292321 – volume: 9 start-page: S104 issue: suppl 4 year: 2009 ident: 10.4065/mcp.2011.0309_bib8 article-title: Herpes simplex virus infections in solid organ transplant recipients publication-title: Am J Transplant doi: 10.1111/j.1600-6143.2009.02900.x – volume: 343 start-page: 1673 year: 2000 ident: 10.4065/mcp.2011.0309_bib126 article-title: Peginterferon alfa-2a in patients with chronic hepatitis C and cirrhosis publication-title: N Engl J Med doi: 10.1056/NEJM200012073432302 – volume: 4 start-page: 324 year: 1998 ident: 10.4065/mcp.2011.0309_bib138 article-title: Survival prolongation in HIV-associated progressive multifocal leukoencephalopathy treated with alpha-interferon: an observational study publication-title: J Neurovirol doi: 10.3109/13550289809114533 – volume: 63 start-page: 2215 year: 2003 ident: 10.4065/mcp.2011.0309_bib164 article-title: Adefovir dipivoxil: a review of its use in chronic hepatitis B publication-title: Drugs doi: 10.2165/00003495-200363200-00007 – volume: 364 start-page: 2405 year: 2011 ident: 10.4065/mcp.2011.0309_bib201 article-title: Telaprevir for previously untreated chronic hepatitis C virus infection publication-title: N Engl J Med doi: 10.1056/NEJMoa1012912 – volume: 49 start-page: 810 year: 2001 ident: 10.4065/mcp.2011.0309_bib157 article-title: Treatment of acute Nipah encephalitis with ribavirin publication-title: Ann Neurol doi: 10.1002/ana.1062 – volume: 30 start-page: 115 year: 2004 ident: 10.4065/mcp.2011.0309_bib91 article-title: Antiviral drugs in current clinical use publication-title: J Clin Virol doi: 10.1016/j.jcv.2004.02.009 – volume: 55 start-page: i5 issue: suppl 1 year: 2005 ident: 10.4065/mcp.2011.0309_bib98 article-title: Oseltamivir (Tamiflu) and its potential for use in the event of an influenza pandemic publication-title: J Antimicrob Chemother doi: 10.1093/jac/dki018 – volume: 147 start-page: 134 year: 2002 ident: 10.4065/mcp.2011.0309_bib40 article-title: Successful treatment of an aciclovir-resistant herpes simplex type 2 infection with cidofovir in an AIDS patient publication-title: Br J Dermatol doi: 10.1046/j.1365-2133.2002.04747.x – volume: 89 start-page: 779 year: 2010 ident: 10.4065/mcp.2011.0309_bib60 article-title: International consensus guidelines on the management of cytomegalovirus in solid organ transplantation publication-title: Transplantation doi: 10.1097/TP.0b013e3181cee42f – volume: 297 start-page: 1435 year: 2007 ident: 10.4065/mcp.2011.0309_bib105 article-title: Emergence of influenza B viruses with reduced sensitivity to neuraminidase inhibitors publication-title: JAMA doi: 10.1001/jama.297.13.1435 – volume: 7 start-page: 2106 year: 2007 ident: 10.4065/mcp.2011.0309_bib89 article-title: Oral valganciclovir is noninferior to intravenous ganciclovir for the treatment of cytomegalovirus disease in solid organ transplant recipients publication-title: Am J Transplant doi: 10.1111/j.1600-6143.2007.01910.x – volume: 360 start-page: 1827 year: 2009 ident: 10.4065/mcp.2011.0309_bib199 article-title: Telaprevir with peginterferon and ribavirin for chronic HCV genotype 1 infection publication-title: N Engl J Med doi: 10.1056/NEJMoa0806104 – volume: 364 start-page: 1195 year: 2011 ident: 10.4065/mcp.2011.0309_bib195 article-title: Boceprevir for untreated chronic HCV genotype 1 infection publication-title: N Engl J Med doi: 10.1056/NEJMoa1010494 – volume: 22 start-page: 341 year: 1996 ident: 10.4065/mcp.2011.0309_bib13 article-title: Oral acyclovir therapy accelerates pain resolution in patients with herpes zoster: a meta-analysis of placebo-controlled trials publication-title: Clin Infect Dis doi: 10.1093/clinids/22.2.341 – volume: 352 start-page: 2673 year: 2005 ident: 10.4065/mcp.2011.0309_bib168 article-title: Long-term therapy with adefovir dipivoxil for HBeAg-negative chronic hepatitis B publication-title: N Engl J Med doi: 10.1056/NEJMoa042957 – volume: 133 start-page: 467 year: 2002 ident: 10.4065/mcp.2011.0309_bib56 article-title: A randomized controlled clinical trial of intravitreous fomivirsen for treatment of newly diagnosed peripheral cytomegalovirus retinitis in patients with AIDS publication-title: Am J Ophthalmol – volume: 76 start-page: 1171 year: 2001 ident: 10.4065/mcp.2011.0309_bib43 article-title: Cidofovir treatment of progressive multifocal leukoencephalopathy in a patient receiving highly active antiretroviral therapy publication-title: Mayo Clin Proc doi: 10.4065/76.11.1171 – volume: 364 start-page: 2417 year: 2011 ident: 10.4065/mcp.2011.0309_bib202 article-title: Telaprevir for retreatment of HCV infection publication-title: N Engl J Med doi: 10.1056/NEJMoa1013086 – volume: 358 start-page: 958 year: 2001 ident: 10.4065/mcp.2011.0309_bib129 article-title: Peginterferon alfa-2b plus ribavirin compared with interferon alfa-2b plus ribavirin for initial treatment of chronic hepatitis C: a randomised trial publication-title: Lancet doi: 10.1016/S0140-6736(01)06102-5 – volume: 15 start-page: 900 year: 2008 ident: 10.4065/mcp.2011.0309_bib25 article-title: New advances in anti-HSV chemotherapy publication-title: Curr Med Chem doi: 10.2174/092986708783955419 – volume: 168 start-page: 444 year: 1993 ident: 10.4065/mcp.2011.0309_bib62 article-title: A dose-ranging study of daily maintenance intravenous foscarnet therapy for cytomegalovirus retinitis in AIDS publication-title: J Infect Dis doi: 10.1093/infdis/168.2.444 – volume: 32 start-page: 121 issue: suppl A year: 1993 ident: 10.4065/mcp.2011.0309_bib9 article-title: Antivirals for the treatment of herpesvirus infections publication-title: J Antimicrob Chemother doi: 10.1093/jac/32.suppl_A.121 – volume: 60 start-page: 1329 year: 2000 ident: 10.4065/mcp.2011.0309_bib137 article-title: Current recommendations for the treatment of genital herpes publication-title: Drugs doi: 10.2165/00003495-200060060-00007 – volume: 80 start-page: 77 year: 2007 ident: 10.4065/mcp.2011.0309_bib53 article-title: Famciclovir for cutaneous herpesvirus infections: an update and review of new single-day dosing indications publication-title: Cutis – volume: 57 start-page: 945 year: 2006 ident: 10.4065/mcp.2011.0309_bib17 article-title: The aciclovir metabolite CMMG is detectable in the CSF of subjects with neuropsychiatric symptoms during aciclovir and valaciclovir treatment publication-title: J Antimicrob Chemother doi: 10.1093/jac/dkl067 – volume: 310 start-page: 32 year: 1984 ident: 10.4065/mcp.2011.0309_bib146 article-title: Acute interstitial nephritis with the nephrotic syndrome following recombinant leukocyte a interferon therapy for mycosis fungoides publication-title: N Engl J Med doi: 10.1056/NEJM198401053100107 – volume: 36 start-page: 1613 year: 2003 ident: 10.4065/mcp.2011.0309_bib161 article-title: The efficacy of oral ribavirin in the treatment of Crimean-Congo hemorrhagic fever in Iran publication-title: Clin Infect Dis doi: 10.1086/375058 – volume: 357 start-page: 2576 year: 2007 ident: 10.4065/mcp.2011.0309_bib182 article-title: Telbivudine versus lamivudine in patients with chronic hepatitis B publication-title: N Engl J Med doi: 10.1056/NEJMoa066422 – volume: 348 start-page: 808 year: 2003 ident: 10.4065/mcp.2011.0309_bib166 article-title: Adefovir dipivoxil for the treatment of hepatitis B e antigen-positive chronic hepatitis B publication-title: N Engl J Med doi: 10.1056/NEJMoa020681 – volume: 69 start-page: 1003 year: 2009 ident: 10.4065/mcp.2011.0309_bib173 article-title: Entecavir: a review of its use in chronic hepatitis B publication-title: Drugs doi: 10.2165/00003495-200969080-00005 – volume: 374 start-page: 1036 year: 2009 ident: 10.4065/mcp.2011.0309_bib108 article-title: H1N1 pneumonitis treated with intravenous zanamivir publication-title: Lancet doi: 10.1016/S0140-6736(09)61528-2 – volume: 364 start-page: 759 year: 2004 ident: 10.4065/mcp.2011.0309_bib101 article-title: Resistant influenza A viruses in children treated with oseltamivir: descriptive study publication-title: Lancet doi: 10.1016/S0140-6736(04)16934-1 – volume: 39 start-page: 1599 year: 1995 ident: 10.4065/mcp.2011.0309_bib73 article-title: Activity of penciclovir against Epstein-Barr virus publication-title: Antimicrob Agents Chemother doi: 10.1128/AAC.39.7.1599 – volume: 24 start-page: 1113 year: 2001 ident: 10.4065/mcp.2011.0309_bib109 article-title: Zanamivir: a review of clinical safety in individuals at high risk of developing influenza-related complications publication-title: Drug Saf doi: 10.2165/00002018-200124150-00003 – volume: 44 start-page: 309 year: 2006 ident: 10.4065/mcp.2011.0309_bib187 article-title: Tenofovir disoproxil fumarate: role in hepatitis B treatment publication-title: Hepatology doi: 10.1002/hep.21307 – volume: 55 start-page: 533 year: 2006 ident: 10.4065/mcp.2011.0309_bib47 article-title: Intravenous cidofovir-induced resolution of disfiguring cutaneous human papillomavirus infection publication-title: J Am Acad Dermatol doi: 10.1016/j.jaad.2006.01.007 – volume: 4 start-page: 611 year: 2004 ident: 10.4065/mcp.2011.0309_bib84 article-title: Efficacy and safety of valganciclovir vs. oral ganciclovir for prevention of cytomegalovirus disease in solid organ transplant recipients publication-title: Am J Transplant doi: 10.1111/j.1600-6143.2004.00382.x – volume: 38 start-page: 625 year: 2004 ident: 10.4065/mcp.2011.0309_bib165 article-title: Adefovir dipivoxil in the treatment of chronic hepatitis B publication-title: Ann Pharmacother doi: 10.1345/aph.1D362 – volume: 351 start-page: 451 year: 2004 ident: 10.4065/mcp.2011.0309_bib133 article-title: Peginterferon Alfa-2a plus ribavirin versus interferon alfa-2a plus ribavirin for chronic hepatitis C in HIV-coinfected persons publication-title: N Engl J Med doi: 10.1056/NEJMoa032653 – volume: 259 start-page: 1566 year: 1984 ident: 10.4065/mcp.2011.0309_bib66 article-title: Interaction of herpes simplex virus-induced DNA polymerase with 9-(1,3-dihydroxy-2-propoxymethyl)guanine triphosphate publication-title: J Biol Chem doi: 10.1016/S0021-9258(17)43446-6 – volume: 346 start-page: 1119 year: 2002 ident: 10.4065/mcp.2011.0309_bib83 article-title: A controlled trial of valganciclovir as induction therapy for cytomegalovirus retinitis publication-title: N Engl J Med doi: 10.1056/NEJMoa011759 – volume: 98 start-page: 914 year: 1983 ident: 10.4065/mcp.2011.0309_bib1 article-title: Intravenous acyclovir for the treatment of primary genital herpes publication-title: Ann Intern Med doi: 10.7326/0003-4819-98-6-914 – volume: 343 start-page: 1666 year: 2000 ident: 10.4065/mcp.2011.0309_bib124 article-title: Peginterferon alfa-2a in patients with chronic hepatitis C publication-title: N Engl J Med doi: 10.1056/NEJM200012073432301 – volume: 31 start-page: 185 year: 1997 ident: 10.4065/mcp.2011.0309_bib75 article-title: Valacyclovir publication-title: Ann Pharmacother doi: 10.1177/106002809703100211 – volume: 7 start-page: 158 year: 2005 ident: 10.4065/mcp.2011.0309_bib35 article-title: Treatment of verruca vulgaris with topical cidofovir in an immunocompromised patient: a case report and review of the literature publication-title: Transpl Infect Dis doi: 10.1111/j.1399-3062.2005.00099.x – volume: 34 start-page: 489 year: 1990 ident: 10.4065/mcp.2011.0309_bib149 article-title: Hemodialysis clearance of intravenously administered ribavirin publication-title: Antimicrob Agents Chemother doi: 10.1128/AAC.34.3.489 – volume: 40 start-page: 472 year: 2006 ident: 10.4065/mcp.2011.0309_bib180 article-title: Telbivudine: a novel nucleoside analog for chronic hepatitis B publication-title: Ann Pharmacother doi: 10.1345/aph.1G027 – volume: 166 start-page: 49 year: 2006 ident: 10.4065/mcp.2011.0309_bib170 article-title: A double-blind placebo-controlled study of emtricitabine in chronic hepatitis B publication-title: Arch Intern Med doi: 10.1001/archinte.166.1.49 – volume: 450 start-page: 665 year: 2007 ident: 10.4065/mcp.2011.0309_bib191 article-title: Acute interstitial nephritis of HIV-positive patients under atazanavir and tenofovir therapy in a retrospective analysis of kidney biopsies publication-title: Virchows Arch doi: 10.1007/s00428-007-0418-3 – volume: 52 start-page: 225 year: 1996 ident: 10.4065/mcp.2011.0309_bib27 article-title: Cidofovir publication-title: Drugs doi: 10.2165/00003495-199652020-00006 – volume: 157 start-page: 867 year: 2000 ident: 10.4065/mcp.2011.0309_bib141 article-title: Neuropsychiatric symptoms associated with hepatitis C and interferon19 alpha: a review publication-title: Am J Psychiatry doi: 10.1176/appi.ajp.157.6.867 – volume: 32 start-page: 111 year: 1998 ident: 10.4065/mcp.2011.0309_bib18 article-title: Acyclovir- and ganciclovir-induced neurotoxicity publication-title: Ann Pharmacother doi: 10.1345/aph.17135 – volume: 46 start-page: 28 year: 2008 ident: 10.4065/mcp.2011.0309_bib86 article-title: Use of valganciclovir for prevention and treatment of cytomegalovirus disease [editorial] publication-title: Clin Infect Dis doi: 10.1086/523589 – volume: 29 start-page: 31 year: 1998 ident: 10.4065/mcp.2011.0309_bib57 article-title: Fomivirsen publication-title: BETA – volume: 3 start-page: 1561 year: 2002 ident: 10.4065/mcp.2011.0309_bib34 article-title: Role of cidofovir in the treatment of DNA virus infections, other than CMV infections, in immunocompromised patients publication-title: Curr Opin Investig Drugs – volume: 147 start-page: 1577 year: 1987 ident: 10.4065/mcp.2011.0309_bib140 article-title: Psychiatric complications of long-term interferon alfa therapy publication-title: Arch Intern Med doi: 10.1001/archinte.1987.00370090055011 – volume: 88 start-page: 760 year: 1993 ident: 10.4065/mcp.2011.0309_bib143 article-title: Fluoxetine treatment of depression caused by interferon-alpha publication-title: Am J Gastroenterol – volume: 147 start-page: 745 year: 2007 ident: 10.4065/mcp.2011.0309_bib183 article-title: Treatment of hepatitis B e antigen positive chronic hepatitis with telbivudine or adefovir: a randomized trial publication-title: Ann Intern Med doi: 10.7326/0003-4819-147-11-200712040-00183 – volume: 360 start-page: 1839 year: 2009 ident: 10.4065/mcp.2011.0309_bib200 article-title: Telaprevir and peginterferon with or without ribavirin for chronic HCV infection publication-title: N Engl J Med doi: 10.1056/NEJMoa0807650 – volume: 98 start-page: 921 year: 1983 ident: 10.4065/mcp.2011.0309_bib19 article-title: Neurologic symptoms associated with parenteral acyclovir treatment after marrow transplantation publication-title: Ann Intern Med doi: 10.7326/0003-4819-98-6-921 – volume: 42 start-page: 242 year: 2004 ident: 10.4065/mcp.2011.0309_bib22 article-title: Surveillance network for herpes simplex virus resistance to antiviral drugs: 3-year follow-up publication-title: J Clin Microbiol doi: 10.1128/JCM.42.1.242-249.2004 – volume: 168 start-page: 557 year: 1993 ident: 10.4065/mcp.2011.0309_bib68 article-title: A randomized, controlled study of intravenous ganciclovir therapy for cytomegalovirus peripheral retinitis in patients with AIDS publication-title: J Infect Dis doi: 10.1093/infdis/168.3.557 – volume: 119 start-page: 312 year: 1993 ident: 10.4065/mcp.2011.0309_bib112 article-title: Effect of alpha-interferon treatment in patients with hepatitis B e antigen-positive chronic hepatitis B: a meta-analysis publication-title: Ann Intern Med doi: 10.7326/0003-4819-119-4-199308150-00011 – volume: 60 start-page: 1295 year: 2006 ident: 10.4065/mcp.2011.0309_bib181 article-title: Novel anti-hepatitis B agents: a focus on telbivudine publication-title: Int J Clin Pract doi: 10.1111/j.1742-1241.2006.01143.x – volume: 350 start-page: 1729 year: 1997 ident: 10.4065/mcp.2011.0309_bib70 article-title: Randomised trial of efficacy and safety of oral ganciclovir in the prevention of cytomegalovirus disease in liver-transplant recipients [published correction appears in Lancet. 1998;351(9100):454] publication-title: Lancet doi: 10.1016/S0140-6736(97)05535-9 – volume: 170 start-page: 570 year: 1994 ident: 10.4065/mcp.2011.0309_bib38 article-title: Treatment with intravenous (S)-1-[3-hydroxy-2-(phosphonylmethoxy)propyl]-cytosine of acyclovir-resistant mucocutaneous infection with herpes simplex virus in a patient with AIDS publication-title: J Infect Dis doi: 10.1093/infdis/170.3.570 – volume: 49 start-page: 725 year: 2009 ident: 10.4065/mcp.2011.0309_bib179 article-title: Population pharmacokinetics of telbivudine and determination of dose adjustment for patients with renal impairment publication-title: J Clin Pharmacol doi: 10.1177/0091270009333555 – volume: 301 start-page: 1034 year: 2009 ident: 10.4065/mcp.2011.0309_bib104 article-title: Infections with oseltamivir-resistant influenza A(H1N1) virus in the United States publication-title: JAMA doi: 10.1001/jama.2009.294 – volume: 20 start-page: 1083 year: 2001 ident: 10.4065/mcp.2011.0309_bib39 article-title: Successful treatment of foscarnet-resistant herpes simplex stomatitis with intravenous cidofovir in a child publication-title: Pediatr Infect Dis J doi: 10.1097/00006454-200111000-00016 – volume: 6 start-page: 38 year: 1998 ident: 10.4065/mcp.2011.0309_bib52 article-title: A review of famciclovir in the management of genital herpes publication-title: Infect Dis Obstet Gynecol doi: 10.1002/(SICI)1098-0997(1998)6:1<38::AID-IDOG8>3.0.CO;2-3 – volume: 9 start-page: S108 issue: suppl 4 year: 2009 ident: 10.4065/mcp.2011.0309_bib77 article-title: Varicella zoster virus (VZV) in solid organ transplant recipients publication-title: Am J Transplant doi: 10.1111/j.1600-6143.2009.02901.x – volume: 41 start-page: 104 year: 1991 ident: 10.4065/mcp.2011.0309_bib58 article-title: Foscarnet: a review of its antiviral activity, pharmacokinetic properties and therapeutic use in immunocompromised patients with cytomegalovirus retinitis publication-title: Drugs doi: 10.2165/00003495-199141010-00009 – volume: 42 start-page: 329 year: 2005 ident: 10.4065/mcp.2011.0309_bib135 article-title: Efficacy of a 24-week course of PEG-interferon alpha-2b monotherapy in patients with acute hepatitis C after failure of spontaneous clearance publication-title: J Hepatol doi: 10.1016/j.jhep.2004.11.021 – volume: 6 start-page: 2134 year: 2006 ident: 10.4065/mcp.2011.0309_bib85 article-title: Prophylactic versus preemptive oral valganciclovir for the management of cytomegalovirus infection in adult renal transplant recipients publication-title: Am J Transplant doi: 10.1111/j.1600-6143.2006.01413.x – volume: 132 start-page: 1979 year: 2007 ident: 10.4065/mcp.2011.0309_bib197 article-title: The hepatitis C virus life cycle as a target for new antiviral therapies publication-title: Gastroenterology doi: 10.1053/j.gastro.2007.03.116 – volume: 341 start-page: 1256 year: 1999 ident: 10.4065/mcp.2011.0309_bib176 article-title: Lamivudine as initial treatment for chronic hepatitis B in the United States publication-title: N Engl J Med doi: 10.1056/NEJM199910213411702 – volume: 27 start-page: 494 year: 2007 ident: 10.4065/mcp.2011.0309_bib155 article-title: Adverse events associated with high-dose ribavirin: evidence from the Toronto outbreak of severe acute respiratory syndrome publication-title: Pharmacotherapy doi: 10.1592/phco.27.4.494 – volume: 168 start-page: 1137 year: 2008 ident: 10.4065/mcp.2011.0309_bib7 article-title: The treatment of herpes simplex infections: an evidence-based review publication-title: Arch Intern Med doi: 10.1001/archinte.168.11.1137 – volume: 44 start-page: 495 year: 2005 ident: 10.4065/mcp.2011.0309_bib81 article-title: Pharmacokinetic profile of ganciclovir after its oral administration and from its prodrug, valganciclovir, in solid organ transplant recipients publication-title: Clin Pharmacokinet doi: 10.2165/00003088-200544050-00003 – volume: 277 start-page: 1374 year: 1997 ident: 10.4065/mcp.2011.0309_bib74 article-title: Penciclovir cream for the treatment of herpes simplex labialis: a randomized, multicenter, double-blind, placebo-controlled trial publication-title: JAMA doi: 10.1001/jama.1997.03540410052030 – ident: 10.4065/mcp.2011.0309_bib194 doi: 10.1345/aph.1P744 – volume: 36 start-page: 41 year: 1999 ident: 10.4065/mcp.2011.0309_bib174 article-title: Clinical pharmacokinetics of lamivudine publication-title: Clin Pharmacokinet doi: 10.2165/00003088-199936010-00004 – volume: 22 start-page: 99 year: 2008 ident: 10.4065/mcp.2011.0309_bib190 article-title: Tenofovir-associated Fanconi syndrome: review of the FDA adverse event reporting system publication-title: AIDS Patient Care STDS doi: 10.1089/apc.2007.0052 – volume: 365 start-page: 123 year: 2005 ident: 10.4065/mcp.2011.0309_bib118 article-title: Pegylated Interferon alfa-2b alone or in combination with lamivudine for HBeAg-positive chronic hepatitis B: a randomised trial publication-title: Lancet doi: 10.1016/S0140-6736(05)17701-0 – volume: 23 start-page: 19 issue: suppl 1 year: 2003 ident: 10.4065/mcp.2011.0309_bib111 article-title: Pegylation of interferon alfa: structural and pharmacokinetic properties publication-title: Semin Liver Dis – volume: 37 start-page: 245 year: 2001 ident: 10.4065/mcp.2011.0309_bib55 article-title: Fomivirsen publication-title: Drugs Today (Barc) doi: 10.1358/dot.2001.37.4.620590 – volume: 49 start-page: 1335 year: 2009 ident: 10.4065/mcp.2011.0309_bib130 article-title: Diagnosis, management, and treatment of hepatitis C: an update publication-title: Hepatology doi: 10.1002/hep.22759 – volume: 330 start-page: 88 year: 1994 ident: 10.4065/mcp.2011.0309_bib119 article-title: Treatment of chronic hepatitis D with interferon alfa-2a publication-title: N Engl J Med doi: 10.1056/NEJM199401133300202 – volume: 8 start-page: 651 year: 2002 ident: 10.4065/mcp.2011.0309_bib67 article-title: The impact of human herpesvirus-6 and -7 infection on the outcome of liver transplantation publication-title: Liver Transpl doi: 10.1053/jlts.2002.34966 – volume: 346 start-page: 1156 year: 1995 ident: 10.4065/mcp.2011.0309_bib178 article-title: Hepatitis B reactivation after lamivudine publication-title: Lancet doi: 10.1016/S0140-6736(95)91829-9 – volume: 31 start-page: 1 year: 1996 ident: 10.4065/mcp.2011.0309_bib51 article-title: The clinical pharmacokinetics of famciclovir publication-title: Clin Pharmacokinet doi: 10.2165/00003088-199631010-00001 – volume: 292 start-page: 2839 year: 2004 ident: 10.4065/mcp.2011.0309_bib131 article-title: Pegylated interferon alfa-2b vs standard interferon alfa-2b, plus ribavirin, for chronic hepatitis C in HIV-infected patients: a randomized controlled trial publication-title: JAMA doi: 10.1001/jama.292.23.2839 – volume: 347 start-page: 975 year: 2002 ident: 10.4065/mcp.2011.0309_bib128 article-title: Peginterferon alfa-2a plus ribavirin for chronic hepatitis C virus infection publication-title: N Engl J Med doi: 10.1056/NEJMoa020047 – volume: 28 start-page: 184 year: 2006 ident: 10.4065/mcp.2011.0309_bib172 article-title: Entecavir for the treatment of chronic hepatitis B virus infection publication-title: Clin Ther doi: 10.1016/j.clinthera.2006.02.012 – volume: 33 start-page: 167 year: 1999 ident: 10.4065/mcp.2011.0309_bib50 article-title: Iritis associated with intravenous cidofovir publication-title: Ann Pharmacother doi: 10.1345/aph.17453 – volume: 106 start-page: 459 year: 1999 ident: 10.4065/mcp.2011.0309_bib16 article-title: Crystal-induced acute renal failure publication-title: Am J Med doi: 10.1016/S0002-9343(99)00041-8 – volume: 57 start-page: 8 year: 2006 ident: 10.4065/mcp.2011.0309_bib150 article-title: Treating HCV with ribavirin analogues and ribavirin-like molecules publication-title: J Antimicrob Chemother doi: 10.1093/jac/dki405 – volume: 40 start-page: 2721 year: 1996 ident: 10.4065/mcp.2011.0309_bib59 article-title: Effect of foscarnet on quantities of cytomegalovirus and human immunodeficiency virus in blood of persons with AIDS publication-title: Antimicrob Agents Chemother doi: 10.1128/AAC.40.12.2721 – volume: 60 start-page: 193 year: 2007 ident: 10.4065/mcp.2011.0309_bib48 article-title: Simultaneous development of Fanconi syndrome and acute renal failure associated with cidofovir publication-title: J Antimicrob Chemother doi: 10.1093/jac/dkm143 – volume: 2 start-page: 571 year: 1982 ident: 10.4065/mcp.2011.0309_bib2 article-title: Efficacy of oral acyclovir in the treatment of initial and recurrent genital herpes publication-title: Lancet doi: 10.1016/S0140-6736(82)90658-4 – volume: 99 start-page: 261 year: 1997 ident: 10.4065/mcp.2011.0309_bib156 article-title: Treatment of severe La Crosse encephalitis with intravenous ribavirin following diagnosis by brain biopsy publication-title: Pediatrics doi: 10.1542/peds.99.2.261 – volume: 117 start-page: 358 year: 1992 ident: 10.4065/mcp.2011.0309_bib12 article-title: Treatment of adult varicella with oral acyclovir: a randomized, placebo-controlled trial publication-title: Ann Intern Med doi: 10.7326/0003-4819-117-5-358 – volume: 348 start-page: 800 year: 2003 ident: 10.4065/mcp.2011.0309_bib167 article-title: Adefovir dipivoxil for the treatment of hepatitis B e antigen-negative chronic hepatitis B publication-title: N Engl J Med doi: 10.1056/NEJMoa021812 – volume: 205 start-page: 300 year: 2002 ident: 10.4065/mcp.2011.0309_bib147 article-title: Alopecia areata during interferon alpha-2b/ribavirin therapy publication-title: Dermatology doi: 10.1159/000065841 – volume: 62 start-page: 710 year: 2006 ident: 10.4065/mcp.2011.0309_bib148 article-title: Pharmacokinetics of ribavirin in patients with hepatitis C virus publication-title: Br J Clin Pharmacol doi: 10.1111/j.1365-2125.2006.02704.x – volume: 16 start-page: 114 year: 2003 ident: 10.4065/mcp.2011.0309_bib23 article-title: Herpes simplex virus resistance to acyclovir and penciclovir after two decades of antiviral therapy publication-title: Clin Microbiol Rev doi: 10.1128/CMR.16.1.114-128.2003 – volume: 50 start-page: 873 year: 1995 ident: 10.4065/mcp.2011.0309_bib113 article-title: Interferon-alpha-2a: a review of its pharmacological properties and therapeutic use in the management of viral hepatitis publication-title: Drugs doi: 10.2165/00003495-199550050-00007 – volume: 333 start-page: 615 year: 1995 ident: 10.4065/mcp.2011.0309_bib69 article-title: Oral ganciclovir as maintenance treatment for cytomegalovirus retinitis in patients with AIDS publication-title: N Engl J Med doi: 10.1056/NEJM199509073331002 – start-page: CD000181 year: 2007 ident: 10.4065/mcp.2011.0309_bib152 article-title: Ribavirin for respiratory syncytial virus infection of the lower respiratory tract in infants and young children publication-title: Cochrane Database Syst Rev – volume: 132 start-page: 1767 year: 2007 ident: 10.4065/mcp.2011.0309_bib198 article-title: Dynamic hepatitis C virus genotypic and phenotypic changes in patients treated with the protease inhibitor telaprevir publication-title: Gastroenterology doi: 10.1053/j.gastro.2007.02.037 – volume: 116 start-page: 633 year: 1990 ident: 10.4065/mcp.2011.0309_bib11 article-title: Acyclovir treatment of varicella in otherwise healthy children publication-title: J Pediatr doi: 10.1016/S0022-3476(05)81618-X – volume: 352 start-page: 2682 year: 2005 ident: 10.4065/mcp.2011.0309_bib116 article-title: Peginterferon alfa-2a, lamivudine, and the combination for HBeAg-positive chronic hepatitis B publication-title: N Engl J Med doi: 10.1056/NEJMoa043470 – volume: 32 start-page: 1181 year: 1998 ident: 10.4065/mcp.2011.0309_bib31 article-title: Cidofovir in the treatment of cytomegaloviral disease publication-title: Ann Pharmacother doi: 10.1345/aph.17312 – volume: 38 start-page: 2454 year: 1994 ident: 10.4065/mcp.2011.0309_bib54 article-title: Safety of famciclovir in patients with herpes zoster and genital herpes publication-title: Antimicrob Agents Chemother doi: 10.1128/AAC.38.10.2454 – volume: 353 start-page: 2667 year: 2005 ident: 10.4065/mcp.2011.0309_bib102 article-title: Oseltamivir resistance during treatment of influenza A (H5N1) infection publication-title: N Engl J Med doi: 10.1056/NEJMoa054512 – volume: 364 start-page: 1207 year: 2011 ident: 10.4065/mcp.2011.0309_bib196 article-title: Boceprevir for previously treated chronic HCV genotype 1 infection publication-title: N Engl J Med doi: 10.1056/NEJMoa1009482 – volume: 35 start-page: 371 year: 2004 ident: 10.4065/mcp.2011.0309_bib10 article-title: Relapse of herpes encephalitis after acyclovir therapy: report of two new cases and review of the literature publication-title: Neuropediatrics doi: 10.1055/s-2004-830372 – volume: 61 start-page: 2263 year: 2001 ident: 10.4065/mcp.2011.0309_bib125 article-title: Peginterferon-alpha-2a (40 kD): a review of its use in the management of chronic hepatitis C publication-title: Drugs doi: 10.2165/00003495-200161150-00013 – volume: 315 start-page: 1059 year: 1986 ident: 10.4065/mcp.2011.0309_bib136 article-title: Interferon therapy for condylomata acuminata publication-title: N Engl J Med doi: 10.1056/NEJM198610233151704 – volume: 351 start-page: 438 year: 2004 ident: 10.4065/mcp.2011.0309_bib132 article-title: Peginterferon Alfa-2a plus ribavirin for chronic hepatitis C virus infection in HIV-infected patients publication-title: N Engl J Med doi: 10.1056/NEJMoa040842 – volume: 150 start-page: 1 year: 1984 ident: 10.4065/mcp.2011.0309_bib6 article-title: A collaborative study of patient-initiated treatment of recurrent genital herpes with topical acyclovir or placebo publication-title: J Infect Dis doi: 10.1093/infdis/150.1.1 – volume: 42 start-page: 2240 year: 1998 ident: 10.4065/mcp.2011.0309_bib33 article-title: Incidence of foscarnet resistance and cidofovir resistance in patients treated for cytomegalovirus retinitis publication-title: Antimicrob Agents Chemother doi: 10.1128/AAC.42.9.2240 – volume: 26 start-page: 1745 year: 2006 ident: 10.4065/mcp.2011.0309_bib171 article-title: Entecavir: a new nucleoside analog for the treatment of chronic hepatitis B infection publication-title: Pharmacotherapy doi: 10.1592/phco.26.12.1745 – volume: 126 start-page: 1740 year: 2004 ident: 10.4065/mcp.2011.0309_bib120 article-title: Long-term benefit of interferon alpha therapy of chronic hepatitis D: regression of advanced hepatic fibrosis publication-title: Gastroenterology doi: 10.1053/j.gastro.2004.03.017 – volume: 21 start-page: 301 year: 2003 ident: 10.4065/mcp.2011.0309_bib37 article-title: Topical cidofovir for the treatment of dermatologic conditions: verruca, condyloma, intraepithelial neoplasia, herpes simplex and its potential use in smallpox publication-title: Dermatol Clin doi: 10.1016/S0733-8635(02)00116-X – volume: 42 start-page: 283 year: 2006 ident: 10.4065/mcp.2011.0309_bib193 article-title: Tenofovir-associated acute and chronic kidney disease: a case of multiple drug interactions publication-title: Clin Infect Dis doi: 10.1086/499048 – volume: 47 start-page: 339 year: 2008 ident: 10.4065/mcp.2011.0309_bib99 article-title: Comparison of the clinical effectiveness of oseltamivir and zanamivir against influenza virus infection in children publication-title: Clin Infect Dis doi: 10.1086/589748 – volume: 27 start-page: 1458 year: 1993 ident: 10.4065/mcp.2011.0309_bib20 article-title: Vesicular eruptions following acyclovir administration publication-title: Ann Pharmacother doi: 10.1177/106002809302701208 – volume: 336 start-page: 755 year: 1990 ident: 10.4065/mcp.2011.0309_bib63 article-title: Foscarnet and crystals in glomerular capillary lumens publication-title: Lancet doi: 10.1016/0140-6736(90)92253-E – volume: 251 start-page: 2103 year: 1984 ident: 10.4065/mcp.2011.0309_bib5 article-title: Treatment of recurrent genital herpes simplex infections with oral acyclovir: a controlled trial publication-title: JAMA doi: 10.1001/jama.1984.03340400031020 – volume: 9 start-page: S78 issue: suppl 4 year: 2009 ident: 10.4065/mcp.2011.0309_bib61 article-title: Cytomegalovirus in solid organ transplant recipients publication-title: Am J Transplant doi: 10.1111/j.1600-6143.2009.02897.x – volume: 35 start-page: 741 year: 2001 ident: 10.4065/mcp.2011.0309_bib44 article-title: Use of cidofovir in progressive multifocal leukoencephalopathy publication-title: Ann Pharmacother doi: 10.1345/aph.10338 – volume: 48 start-page: 383 year: 2008 ident: 10.4065/mcp.2011.0309_bib188 article-title: Potency of tenofovir in chronic hepatitis B: mono or combination therapy? publication-title: J Hepatol doi: 10.1016/j.jhep.2007.12.006 – volume: 23 start-page: 23 issue: suppl 1 year: 2003 ident: 10.4065/mcp.2011.0309_bib110 article-title: Pharmacokinetics of peginterferons publication-title: Semin Liver Dis – volume: 83 start-page: 1153 year: 1999 ident: 10.4065/mcp.2011.0309_bib49 article-title: Anterior uveitis associated with intravenous cidofovir use in patients with cytomegalovirus retinitis publication-title: Br J Ophthalmol doi: 10.1136/bjo.83.10.1153 – volume: 59 start-page: 827 year: 2007 ident: 10.4065/mcp.2011.0309_bib169 article-title: Progress in the treatment of chronic hepatitis B: long-term experience with adefovir dipivoxil publication-title: J Antimicrob Chemother doi: 10.1093/jac/dkl551 – volume: 1 start-page: 242 year: 1983 ident: 10.4065/mcp.2011.0309_bib21 article-title: Megaloblastic haemopoiesis due to acyclovir publication-title: Lancet doi: 10.1016/S0140-6736(83)92618-1 – volume: 16 start-page: 25 year: 2000 ident: 10.4065/mcp.2011.0309_bib65 article-title: Recent advances in the therapy and prevention of CMV infections publication-title: J Clin Virol doi: 10.1016/S1386-6532(99)00065-7 – start-page: CD002898 year: 2008 ident: 10.4065/mcp.2011.0309_bib90 article-title: Therapeutic interventions for herpes simplex virus epithelial keratitis publication-title: Cochrane Database Syst Rev – volume: 4 start-page: 66 issue: suppl 10 year: 2004 ident: 10.4065/mcp.2011.0309_bib14 article-title: Other herpesviruses: HHV-6, HHV-7, HHV-8, HSV-1 and -2, VZV publication-title: Am J Transplant – volume: 37 start-page: 1139 year: 2003 ident: 10.4065/mcp.2011.0309_bib154 article-title: Common adverse events associated with the use of ribavirin for severe acute respiratory syndrome in Canada publication-title: Clin Infect Dis doi: 10.1086/378304 – volume: 13 start-page: 1 issue: 11 year: 2009 ident: 10.4065/mcp.2011.0309_bib92 article-title: Amantadine, oseltamivir and zanamivir for the prophylaxis of influenza (including a review of existing guidance no. 67): a systematic review and economic evaluation publication-title: Health Technol Assess doi: 10.3310/hta13110 – volume: 437 start-page: 1108 year: 2005 ident: 10.4065/mcp.2011.0309_bib103 article-title: Avian flu: isolation of drug-resistant H5N1 virus publication-title: Nature doi: 10.1038/4371108a – volume: 362 start-page: 88 issue: 1 year: 2010 ident: 10.4065/mcp.2011.0309_bib107 article-title: Intravenous zanamivir for oseltamivir-resistant 2009 H1N1 influenza [letter] publication-title: N Engl J Med doi: 10.1056/NEJMc0910893 – start-page: CD005445 issue: 1 year: 2010 ident: 10.4065/mcp.2011.0309_bib127 article-title: Ribavirin plus interferon versus interferon for chronic hepatitis C publication-title: Cochrane Database Syst Rev – volume: 68 start-page: 2301 year: 2004 ident: 10.4065/mcp.2011.0309_bib26 article-title: Discovery and development of BVDU (brivudin) as a therapeutic for the treatment of herpes zoster publication-title: Biochem Pharmacol doi: 10.1016/j.bcp.2004.07.039 – volume: 345 start-page: 1452 year: 2001 ident: 10.4065/mcp.2011.0309_bib134 article-title: Treatment of acute hepatitis C with interferon alfa-2b publication-title: N Engl J Med doi: 10.1056/NEJMoa011232 – volume: 148 start-page: 1757 year: 2003 ident: 10.4065/mcp.2011.0309_bib72 article-title: Profiling penciclovir susceptibility and prevalence of resistance of herpes simplex virus isolates across eleven clinical trials publication-title: Arch Virol doi: 10.1007/s00705-003-0124-7 – volume: 28 start-page: 67 year: 2009 ident: 10.4065/mcp.2011.0309_bib153 article-title: Efficacy of oral ribavirin in lung transplant patients with respiratory syncytial virus lower respiratory tract infection publication-title: J Heart Lung Transplant doi: 10.1016/j.healun.2008.10.008 – volume: 13 start-page: 1001 year: 2008 ident: 10.4065/mcp.2011.0309_bib36 article-title: Low-dose cidofovir for the treatment of polyomavirus-associated nephropathy: two case reports and review of the literature publication-title: Antivir Ther doi: 10.1177/135965350801300806 – volume: 37 start-page: 167 year: 1999 ident: 10.4065/mcp.2011.0309_bib80 article-title: Pharmacokinetics of valganciclovir and ganciclovir following multiple oral dosages of valganciclovir in HIV- and CMV-seropositive volunteers publication-title: Clin Pharmacokinet doi: 10.2165/00003088-199937020-00005 – volume: 178 start-page: 1821 year: 1998 ident: 10.4065/mcp.2011.0309_bib32 article-title: In vitro antiviral susceptibilities of isolates from cytomegalovirus retinitis patients receiving first- or second-line cidofovir therapy: relationship to clinical outcome publication-title: J Infect Dis doi: 10.1086/314487 – volume: 339 start-page: 61 year: 1998 ident: 10.4065/mcp.2011.0309_bib177 article-title: A one-year trial of lamivudine for chronic hepatitis B publication-title: N Engl J Med doi: 10.1056/NEJM199807093390201 – volume: 156 start-page: 1729 year: 1996 ident: 10.4065/mcp.2011.0309_bib76 article-title: A large-scale, placebo-controlled, dose-ranging trial of peroral valaciclovir for episodic treatment of recurrent herpes genitalis publication-title: Arch Intern Med doi: 10.1001/archinte.1996.00440140169018 – volume: 338 start-page: 1268 year: 1991 ident: 10.4065/mcp.2011.0309_bib145 article-title: Liver failure due to recombinant alpha interferon publication-title: Lancet doi: 10.1016/0140-6736(91)92132-L – volume: 37 start-page: 849 year: 2003 ident: 10.4065/mcp.2011.0309_bib185 article-title: Tenofovir disoproxil fumarate publication-title: Ann Pharmacother doi: 10.1345/aph.1C388 – volume: 2 start-page: 94 year: 2008 ident: 10.4065/mcp.2011.0309_bib192 article-title: Acute renal failure in an AIDS patient on tenofovir: a case report publication-title: J Med Case Reports doi: 10.1186/1752-1947-2-94 – volume: 39 start-page: 1724 year: 2004 ident: 10.4065/mcp.2011.0309_bib142 article-title: Spectrum of pulmonary toxicity associated with the use of interferon therapy for hepatitis C: case report and review of the literature publication-title: Clin Infect Dis doi: 10.1086/425746 – volume: 12 start-page: 333 year: 2005 ident: 10.4065/mcp.2011.0309_bib115 article-title: Treatment of chronic hepatitis B publication-title: J Viral Hepat doi: 10.1111/j.1365-2893.2005.00599.x |
| SSID | ssj0007994 |
| Score | 2.4705794 |
| SecondaryResourceType | review_article |
| Snippet | Most viral diseases, with the exception of those caused by human immunodeficiency virus, are self-limited illnesses that do not require specific antiviral... Abstract Most viral diseases, with the exception of those caused by human immunodeficiency virus, are self-limited illnesses that do not require specific... |
| SourceID | pubmedcentral proquest gale pubmed pascalfrancis crossref elsevier |
| SourceType | Open Access Repository Aggregation Database Index Database Enrichment Source Publisher |
| StartPage | 1009 |
| SubjectTerms | Acyclovir - analogs & derivatives Acyclovir - pharmacology Acyclovir - therapeutic use Adenine - analogs & derivatives Adenine - pharmacology Adenine - therapeutic use Amantadine - pharmacology Antibiotics. Antiinfectious agents. Antiparasitic agents Antiviral agents Antiviral Agents - pharmacology Antiviral Agents - therapeutic use Biological and medical sciences Comorbidity Diagnosis Drug therapy Drug Therapy, Combination Foscarnet - pharmacology Foscarnet - therapeutic use Ganciclovir - analogs & derivatives Ganciclovir - pharmacology Ganciclovir - therapeutic use General aspects Guanine - analogs & derivatives Guanine - pharmacology Guanine - therapeutic use Health aspects Hepatitis - drug therapy Hepatitis B, Chronic - drug therapy Hepatitis C - drug therapy Hepatitis C - epidemiology Herpesviridae Infections - drug therapy HIV infection HIV Infections - drug therapy HIV Infections - epidemiology Human viral diseases Humans Infectious diseases Influenza, Human - drug therapy Interferons - pharmacology Interferons - therapeutic use Internal Medicine Lamivudine - pharmacology Lamivudine - therapeutic use Medical sciences Nucleosides - pharmacology Nucleosides - therapeutic use Oligopeptides - pharmacology Oligopeptides - therapeutic use Organophosphonates - pharmacology Organophosphonates - therapeutic use Oseltamivir - pharmacology Oseltamivir - therapeutic use Pharmacology. Drug treatments Proline - analogs & derivatives Proline - pharmacology Proline - therapeutic use Protease Inhibitors - therapeutic use Pyrimidinones - pharmacology Pyrimidinones - therapeutic use Ribavirin - pharmacology Ribavirin - therapeutic use Symposium on Antimicrobial Therapy Telbivudine Thymidine - analogs & derivatives Valacyclovir Valganciclovir Valine - analogs & derivatives Valine - pharmacology Valine - therapeutic use Viral diseases Viral diseases of the lymphoid tissue and the blood. Aids Virus Replication - drug effects Zanamivir - pharmacology Zanamivir - therapeutic use |
| Title | Antiviral Drugs for Viruses Other Than Human Immunodeficiency Virus |
| URI | https://www.clinicalkey.com/#!/content/1-s2.0-S0025619611652439 https://www.clinicalkey.es/playcontent/1-s2.0-S0025619611652439 https://dx.doi.org/10.4065/mcp.2011.0309 https://www.ncbi.nlm.nih.gov/pubmed/21964179 https://www.proquest.com/docview/894882652 https://www.proquest.com/docview/896240964 https://pubmed.ncbi.nlm.nih.gov/PMC3184032 |
| Volume | 86 |
| WOSCitedRecordID | wos000295664300012&url=https%3A%2F%2Fcvtisr.summon.serialssolutions.com%2F%23%21%2Fsearch%3Fho%3Df%26include.ft.matches%3Dt%26l%3Dnull%26q%3D |
| hasFullText | 1 |
| inHoldings | 1 |
| isFullTextHit | |
| isPrint | |
| journalDatabaseRights | – providerCode: PRVPQU databaseName: Consumer Health Database (ProQuest) customDbUrl: eissn: 1942-5546 dateEnd: 20201231 omitProxy: false ssIdentifier: ssj0007994 issn: 0025-6196 databaseCode: M0R dateStart: 19970101 isFulltext: true titleUrlDefault: https://search.proquest.com/familyhealth providerName: ProQuest – providerCode: PRVPQU databaseName: Nursing & Allied Health Database customDbUrl: eissn: 1942-5546 dateEnd: 20201231 omitProxy: false ssIdentifier: ssj0007994 issn: 0025-6196 databaseCode: 7RV dateStart: 19970101 isFulltext: true titleUrlDefault: https://search.proquest.com/nahs providerName: ProQuest – providerCode: PRVPQU databaseName: ProQuest Central customDbUrl: eissn: 1942-5546 dateEnd: 20201231 omitProxy: false ssIdentifier: ssj0007994 issn: 0025-6196 databaseCode: BENPR dateStart: 19970101 isFulltext: true titleUrlDefault: https://www.proquest.com/central providerName: ProQuest – providerCode: PRVPQU databaseName: ProQuest_Health & Medical Collection customDbUrl: eissn: 1942-5546 dateEnd: 20201231 omitProxy: false ssIdentifier: ssj0007994 issn: 0025-6196 databaseCode: 7X7 dateStart: 19970101 isFulltext: true titleUrlDefault: https://search.proquest.com/healthcomplete providerName: ProQuest – providerCode: PRVPQU databaseName: Public Health Database customDbUrl: eissn: 1942-5546 dateEnd: 20201231 omitProxy: false ssIdentifier: ssj0007994 issn: 0025-6196 databaseCode: 8C1 dateStart: 19970101 isFulltext: true titleUrlDefault: https://search.proquest.com/publichealth providerName: ProQuest – providerCode: PRVPQU databaseName: Science Database customDbUrl: eissn: 1942-5546 dateEnd: 20201231 omitProxy: false ssIdentifier: ssj0007994 issn: 0025-6196 databaseCode: M2P dateStart: 19970101 isFulltext: true titleUrlDefault: https://search.proquest.com/sciencejournals providerName: ProQuest |
| link | http://cvtisr.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwpV3db9MwELdgQwgJ8f0RBsUPCF4Ic5zYTp5QKZtAYqUao-qb5TgOqwRpaVr-fu4SJ1DU7YUXS5XPTXJ3vvudP-4IeQGRTm6MyUOeli5MZBqHhmVFmFpQH4AHpWqWsqef1HiczmbZxJ_Nqf2xys4mNoa6WFhcIz9MM1A1LgV_u_wZYtEo3Fz1FTSukv0IXTeoszqd9oZYZVnSVWyFOEG2KTbBg4nDH3bp03fGeBRxt0vyNvrm0tTAr7ItdLELif57oPIvD3V8-z-_7Q655aEpHba6dJdccdU9cv3Eb77fJ6NhhaUm4Mn0_WrzraaAd-l0vtrUrqafEUjSs3NT0WZfgH7EiyeLwmGGCrze2VI-IF-Pj85GH0JfgyG0UvJ1aHPrrHFWAU5JWM6UxaR04NMEADnJC8RcpbKKWQh1o4IJFtm0ZDw30kXSqPgh2asWlXtMqHAODKvIoR_CJJFnIgd0IFkSsTyWTgbkdScGbX2CcqyT8V1DoIJS0yA1jVLTKLWAvOzJl21mjosI33Qy1d11UzCQGnzGRQPUrgGu9tO71pGuuWb6S4MYQbMwhxEHaBcQ1o_0CKZFJpc97DmqmW6vvfb2Rg-5AtbGjAPFq4YCLQ7wwxp_cQK4irm7tigHW7ra84UnIhNCqIAcdAqo-4_ptS8gtO8FI4M7R6Zyiw2SSEB-mUwC8qjV9D9_jRndwKoD07bmQE-A-cu3e6r5eZPHPMbVhZg_ufSlDsgN3h27jJ6SvfVq456Ra_bXel6vBs2Ex3ammjaFNh1FA7L_7mg8OYVfJ6xp-eQ3yM5iBg |
| linkProvider | ProQuest |
| linkToHtml | http://cvtisr.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMw1V1LbxMxEB6VggAJ8X4shdYHHheWer1re_eAUNRSNWoakGir3Myu49BIsAnZBMSP4j8ysy8ISnvrgbPHm3g8nvnGngfAM_R0sjRNM1_EI-dHKg79lCdDP7YoPggPRrq8yj7p6X4_HgySD2vwq8mFobDKRieWino4sXRHvh0nKGpCSfF2-s2nplH0uNp00Kik4sD9_IEeW_Gmu4vb-1yIvXdHO_t-3VTAt0qJuW8z62zqrEbDG_GMa0tV1lBJS0QmSgwJRIy01dyi7xYMueSBjUdcZKlygUp1iN-9BJdRjWuKINOD1r_jOkmipkMs-iWqKumJFlNuf7XTulxoSKGPq01gbRNuTNMC92dUNdZYhXz_DeD8yyLu3frPeHkbbtbQm3Wqs3IH1lx-F64e1sEF92Cnk1MrDVwp250tPhcM8Tw7Gc8WhSvYewLK7Og0zVn57sG6lFgzGTqqwEHpqxXlfTi-kCU8gPV8krtHwKRzaDhkhuPoBsoskRmiH8WjgGehcsqDV822G1sXYKc-IF8MOmIkJQalxJCUGJISD1605NOq8shZhK8bGTJNOi0aAIM28awJetUEV9TqqzCBKYTh5mOJiFGSqUaTQOjqAW9n1gitQl7n_dgWibWp0npbfWo6QiNrQy6Q4mVJQRoV-WHTOjEEuUq1yZYoN5fORssXEclESqk92GgE3rSLaaXdA9aOohKll7E0d5MFkShEtomKPHhYnaw_n6aKdWi1kGlLZ64loPrsyyP5-LSs0x7S7UkoHp_7p7bg2v7RYc_0uv2DDbgumhDT4Amsz2cL9xSu2O_zcTHbLJUNg08XfSJ_A5JQtjA |
| linkToPdf | http://cvtisr.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMw1V1LbxMxELZKQRUS4v1YCq0PPC5d4vWu7d0DQlFDRNQ2RKJUvRmv46WRYBOyCYifxr9jZl8QlPbWA-cdb2LvNzPf2OMZQp5BpJMaY1Kfx5nzIxmHvmHJ2I8twAfoQabKreyTQzUcxqenyWiD_GruwmBaZWMTS0M9nlrcI-_ECUCNS8E7WZ0VMer138y--dhACg9am24aFUIO3M8fEL0Vrwc9-NTPOe-_Pd5_59cNBnwrJV_4NrXOGmcVOOGIpUxZrLgGBlsAS5F8jIQiU1YxC3FcMGaCBTbOGE-NdIE0KoT3XiFXVSQEKtcRH7VOQCVJ1HSLhRhFVuU9wXuKzlc7q0uHhpgGud4d1v7hxswU8K2yqsnGOhb8bzLnX96xf-s_Xtfb5GZNyWm30qE7ZMPld8nWUZ10cI_sd3NssQGzpr358nNBgefTk8l8WbiCvkcCTY_PTE7L8xA6wAs307HDyhx4rbWSvE8-XsoUHpDNfJq7R4QK58ChiBSeQ3go0kSkwIokiwKWhtJJj-w1ENC2LsyO_UG-aAjQEDEaEKMRMRoR45EXrfisqkhynuCrBk-6uWYLjkGDrzxvgFo3wBW1WSt0oAuumf5QMmVANdZu4kBpPcLakTVzqxjZRT-2ixDX1XXf1s7qLlewtCHjIPGylEBLC-thTX1hBFYVa5atSO6s6Em7LjwSiRBCeWS7Ab9uJ9Mi3yO0fQrGFU_MTO6mSxSRwHgTGXnkYaVlf16NlezAm8GirehfK4B121ef5JOzsn57iLsqIX984Z_aJVugiPpwMDzYJtd5k3kaPCGbi_nSPSXX7PfFpJjvlHaHkk-XrZC_AUm6vv0 |
| openUrl | ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.atitle=Antiviral+Drugs+for+Viruses+Other+Than+Human+Immunodeficiency+Virus&rft.jtitle=Mayo+Clinic+proceedings&rft.au=Razonable%2C+Raymund+R.&rft.date=2011-10-01&rft.pub=Elsevier+Inc&rft.issn=0025-6196&rft.volume=86&rft.issue=10&rft.spage=1009&rft.epage=1026&rft_id=info:doi/10.4065%2Fmcp.2011.0309&rft.externalDocID=S0025619611652439 |
| thumbnail_m | http://cvtisr.summon.serialssolutions.com/2.0.0/image/custom?url=https%3A%2F%2Fcdn.clinicalkey.com%2Fck-thumbnails%2F00256196%2FS0025619611X62389%2Fcov150h.gif |